CURRICULUM VITAE

PERSONAL INFORMATION

NAME: Seung-Mo Hong, M.D., Ph.D. PRESENT TITLE: Professor

Department of Pathology, Asan Medical Center University of Ulsan College of Medicine

OFFICE ADDRESS: Department of Pathology

Asan Medical Center University of Ulsan College of Medicine 88, Olympic-ro 43-gil, Songpa-gu Seoul 138-736, Korea Tel: +82-2-3010-4558 Fax: +82-2-472-7898

E-MAIL ADDRESS: smhong28@gmail.com

LICENSE -ACTIVE: 1995 - Korean Medical License (No. 55222)

2003 – US Medical License (No.0-554-814-4) EDUCATION:

2002.3-2004.2.20 Ph.D., Department of Medicine The Graduate school University of Ulsan College of Medicine, Seoul, Korea Advisor: Professor Jae Y. Ro

Thesis: Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance

1998.3-2000.2 M.S., Department of Medicine, The Graduate School Kyung Hee University, Seoul, Korea

Advisor: Professor Yong-Ho Cho Thesis: A study of polymorphisms of dopamine beta-hydroxlase and catechol-O methyltranse ferase genes

1989.3-1995.2.23 M.D., Department of Medicine, College of Medicine Kyung Hee University, Seoul, Korea

Hong- 2

POSTGRADUATE TRAINING:

2011.5.23-2011.5.27 Visiting Physician, Division of Liver and Transplantation Pathology UPMC Presbyterian Hospital, Pittsburgh, Pensylvania 2006.7.1-2011.6.30 Research Fellow, Dr. Michael Goggins’ laboratory

Department of Pathology, Division of Gastrointestinal Pathology The Johns Hopkins Medical Institutions, Baltimore, Maryland

2004.7.1-2006.6.30 Research Associate, Dr. Christopher A. Moskaluk’s laboratory

Department of Pathology, University of Virginia Health System Charlottesville, Virginia

2003.5.1-2003.5.31 Visiting Physician, Department of Pathology, The University of Texas

MD Anderson Cancer Center, Houston, Texas 2000.4.1-2003.4.31 Public Health Doctor and Medical Examiner

Division of General Affairs, Suwon District Prosecutor’s Office, Suwon, Korea

1996.3.1-2000.2.28 Resident, Department of Diagnostic Pathology Asan Medical Center

University of Ulsan College of Medicine Seoul, Korea 1995.3.1-1996.2.28 Intern, Asan Medical Center University of Ulsan College of Medicine

Seoul, Korea

PROFESSIONAL EXPERIENCE: 2011.07.01-2012.02.28 Clnical Professor, Department of Pathology Asan Medical Center,

Seoul, Korea 2012.03.01-2018.03.31 Associate Professor, Department of Pathology Asan Medical

Center, University of Ulsan Collge of Medicine, Seoul, Korea 2018.02.01~ 2019.07.31 Faculty (Visiting Researcher),

Division of Gastrointestinal Pathology, Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland

2018.04.01~Current Professor, Department of Pathology Asan Medical Center,

University of Ulsan Collge of Medicine, Seoul, Korea SPECIALITY BOARDS:

2000 Board Certified by the Korean Board of Pathology in Anatomic Pathology

(No. 596)

Hong- 3

LEADERSHIP ACTIVITIES:

2019.07– Current Director, Pathology Executive Committee, Korean Joint Committees on

Pancreas Cancer 2017.03 – Current Course Director, Asan Medical Center Surgical Pathology Update

(Pathology CME Course), Asan Medical Center 2016.09. - Current General Director, Thr Korean Cancer Association 2013.01.- 2018.12 Science Director, The Surgical Pathology Study Group, The Korean

Society of Pathologists 2015.01.-2016.12 Director of International Cooperation, The Korean Society of Pathologists 2013.01.-2014.12 General Director, The Gastrointestinal Pathology Study Group, The

Korean Society of Pathologists 2013.03.-2014.02 Deputy, Department of Pathology, Asan Medical Center, Seoul, Korea 2012.01.-2013.02 Director, Residency and Fellowship Program, Department of Pathology, Asan Medical Center, Seoul, Korea 2010.09.-2010.11 Conference Committee, Baltimore Life Scientists Association, Baltimore,

Maryland 2009.01-2009.12 President, Baltimore Life Scientists Association, Baltimore, Maryland 2000.04-2003.04 Chief Medical Examiner, Division of General Affairs Suwon District Prosecutor’s Office, Suwon, Korea 1999.09-2000.02 Chief Resident, Department of Diagnostic Pathology, Asan Medical

Center, University of Ulsan College of Medicine, Seoul, Korea HONORS AND AWARDS:

2009.11 Chairman , BLSA Conference 2009 Organization Committee. Baltimore Life Scientists Association, Baltimore, Maryland, USA

2008.11 BLSA Postdoctoral/Graduate Student Award, Baltimore Life Scientists

Association, The 2nd BLSA conference, Baltimore, Maryland, USA 2006.6 Scholar-in-Training Award, Pancreatic Cancer 2006: Early Detection and

Novel Therapeutics, American Association for Cancer Research / Lustgarten Foundation / University of North Carolina Special Conference, Chapel Hill, North Carolina, USA

2004.3 Pathologist-in-Training Award for the Outstanding Scientific Presentation,

Hans Popper Hepatopathology Society, United States and Canadian Academy of Pathology, Vancouver, British Columbia, Canada

Hong- 4

2004.3 Merit Award, Korean Pathologist Association of North America, Vancouver, British Columbia, Canada

2001.10 Award of the Best Article, Alumni Association of Kyung Hee University

College of Medicine, Seoul, Korea 2000.3 Resident Award, Korean Pathologist Association of North America,

San Antonio, Texas, USA 1999.3 Resident Award, Korean Pathologist Association of North America, San Francisco, California, USA COMMITTEE MEMBERSHIP:

International Dataset Authoring Committee, Development of a Dataset for the Reporting of Stomach Cancer, International Collaboration on Cancer Reporting (ICCR) (04/2019 ~ Current) International Cooperation Committee, The Korean Society of Pathologists (01/2015 ~ 12/2018) Think Tank Committee, Asan Cancer Institute, Asan Medical Center (01/2015 ~ 12/2016) Management committee, Bioresource center, Asan Medical Center (08/2012 ~ Current) Organizing committee, The 14th Korea-Japan Conjoint Slide Conference of International Association of Pathology (05/2014 ~ 10/2014) Organizing committee, The 23rd Federation Meeting of Korean Basic Medical Scientists (01/2015 ~ 5/2015) Committee of systemaization of pathology report, Asan Medical Center, (07/2011 ~ 02/2014) Director of Residency and Fellowship program, Department of Pathology, Asan Medical Center (01/2012 ~ 02/2013) Academic committee member, 2013 the 8th Asian Pacific International Academy of Pathology Congress. (03/2012 ~ 09/2013) Task force team of the management and usage of bioresource materials, Asan Medical Center, (03/2012 ~ 04/2012) SOCIETY MEMBERSHIPS WITH OFFICES HELD:

1. United States and Canadian Academy of Pathology, Member 2. The Korean Society of Pathologists, Member 3. International Academy of Pathology, Member

Hong- 5

4. European Neuroendocrine Tumor Society, Member 5. Korea Cancer Association, Member 6. Korean Pancreatobiliary Association, Member TEACHING EXPERIENCE:

1996.03-2000.02 Teaching Assistant, Department of Diagnostic Pathology, Asan Medical

Center, University of Ulsan College of Medicine, Seoul, Korea 2012.04-2018.03 Associate Professor, Department of Pathology, Asan Medical Center,

University of Ulsan College of Medicine, Seoul, Korea 2018.04-Current Professor, Department of Pathology, Asan Medical Center, University of

Ulsan College of Medicine, Seoul, Korea THESIS ADVISOR 4. 2016 M.Sc. Thesis of Sung-Joo Kim Thesis: Development of recurrence prediotion biomarker with ultrasensitive-digital PCR on resection margin of surgically resected pancreatic ductal adenocarcinoma specimen 3. 2015 M.Sc. Thesis of Min-Sun Kim Thesis: Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patient 2. 2014. M.Sc. Thesis of Soyeon An Thesis: Histopathologic changes of bile ducts after biliary instrumental insertion in patients with pancreaticoduodenectomy 1. 2013 M.Sc. Thesis of Hosub Park Thesis: Survival effect of tumor size and extrapancreatic extension in surgically resected pancreas cancer patients: Proposal for improved T classification DOCTORATE THESIS COMMITTEE MEMBER

11. 2017 Ph.D. Thesis committee member for Jae Seung So Thesis: Comparison of immunoprofiling between colitis-associated cancer and sporadic colorectal cancer using quantitative multispectral imaging system Advisor: Professor Seung-Jae Myung 10. 2017 Ph.D. Thesis Committee Member for Thesis: Immune infiltrates and prediction of recurrence in rectal cancer after preoperative chemoradiation byu quantitative multiplexed immunohistochemistry Advisor: Professor Seung-Jae Myung

Hong- 6

9. 2017 M.Sc. Thesis Committee Member for Hee Jung Chae, Thesis: Prognostic implication of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma treated with first-line gemcitabine plus cisplatin Advisor: Professor Baek-Yeol Ryoo 8. 2017 Ph.D. Thesis Committee Member for Goeun Bae Thesis: Sympathetic nervous system contributes to gastric cancer progression Advisor: Professor Sung-Jig Lim 7. 2016 M.Sc. Thesis Committee Member for Jiyoon Kim, Thesis: Expression of immune response-related proteins including PD-1 and PD-L1 in colorectal cancer and survival analysis Advisor: Professor Jihoon Kim 6. 2016 M.Sc. Thesis Committee Member for Chan Mee Lee, Thesis: Development of the 5-Fluorouracil releasing patch to prevent the local recurrence in pancreatic cancer Advisor: Professor Song Cheol Kim 5. 2015 Ph.D. Thesis Committee Member for Su Ji Shin Thesis: Multi-gene analysis of circulating tumor DNA in colorectal cancer: Mass spectrometric based analysis Advisor: Professor Jihoon Kim 4. 2015 Ph.D. Thesis Committee Member for Jung Won Kim Thesis: The relationship between KRAS, NRAS, BRAF, PIC3CA, and TP53 mutations and tumor morphology and behavior in colorectal adenocarcinomas Advisor: Professor Se Jin Jang 3. 2015 M.Sc. Thesis Committee Member for Sng Hyun Shin Thesis: Establishing treatment strategy for pancreatic ductal adenocarcinoma according to genetic alterations: K-ras, p53, c-erbB2 and DPC4 gene Advisor: Professor Song Cheol Kim 2. 2015 M.Sc. Thesis Committee Member for Jin Rho Thesis: RGS1 expression is associated with poor prognosis in plasma cell neoplasm Advisor: Professor Chan Sik Park 1. 2013 M.Sc. Thesis Committee Member for Dahye Son Thesis: Neoplasms arising in large gastric hyperplastic polyps: Endoscopic and pathologic features Advisor: Professor Young Soo Park

Hong- 7

AD HOC REVIEWER FROM PEER REVIEW PAPERS:

American Journal of Clinical Pathology American Journal of Surgical Pathology Annals of Gastroenterology Annals of Surgical Oncology APMIS BioMed Research International BJM Case Report British Journal of Pathology Cancer Cancer Biology and Therapy Case Journal Case Reports in Pathology Digestive Surgery Hepatobiliary Pancreas Disease International Histopathology Human Pathology Interdisciplinary Bio Central (IBC) International Journal of Medical Science JAMA Oncology Journal of Clinical Pathology Journal of Pathology and Translational Medicine (Former Korean Journal of Pathology) Laboratory Investigation Molecular Journal of Pathology Oncotarget Pancreas Scientific Reports Virchows Archieve RESEARCH SUPPORT:

1. Ministry of Education, Science, and Technology, Republic of Korea (2012-0461) 5/01/2012-4/30/2015 Title: Development of biomarkers for early detection and prognosis of extrahepatic bile duct cancers 2. Asan Institute for Life Sciences (2013-554) 7/01/2012-6/30/2013 Title: Development of early diagnostic targeted therapeutic markers of small intestinal adenocarcinoma 3. National R&D program for cancer control, Ministry of Health & Welfare, Republic of Korea (1320200) 5/01/2013-4/30/2016 Title: Development of biomarkers of the pancreatic cystic neoplasms with tissues and cystic fluid using epigenomic technologies 4. Asan Institute for Life Sciences (2015-642) 1/01/2015-1/31/2015 Title: Biomarker Development for Diagnosis and Prognostic of Pancreatic Neuroendocrine Tumor

Hong- 8

5. Asan Institute for Life Sciences (2015-554) 1/01/2015-1/31/2015 Title: Establishment of recurrence biomarker with ultra high sensitive detection method on resection margin of the surgically resected pancreatic cancer patients 6. Asan Institute for Life Sciences (2016-554) 5/01/2016-4/30/2017 Title: Development of recurrence prediction biomarker with ultrasensitive-digital PCR on resection margin of surgically resected pancreatic ductal adenocarcinoma specimen 7. National R&D program for cancer control, Ministry of Health & Welfare, Republic of Korea 5/01/2015-4/30/2020 Title: Development of the first-in-class therapeutic antibodies for treatment of pancreatic cancer (P.I.: Sang Seok Koh, Dong-A University) as Co P.I. 8. Ministry of Education, Science, and Technology, Republic of Korea (NRF-2016R1A2B4009381) 6/01/2016-5/31/2019 Title: Development of diagnostic and prediction biomarkers of the pancreatic neuroendocrine tumors using epigenomic technologies

Hong- 9

BIBLIOGRAPHY:

Book

Hong SM (Publisher). BLSA Conference 2009. Baltimore Life Scientists Association, Baltimore, MD, 2009.

Book Chaper

16. Basturk O, Hong SM, Maitra A, Esposito I, Kloppel G, Fukushima N, Maitra A, Furukawa T, Zamboni G. Pancreatic mucinous cystic neoplasm. In: WHO Classification of Tumours of the Digestive System. 5th Ed. WHO Classification of Tumours Editorial Board. (Ed), International Agency for Research on Cancer, Lyon, France, 2019.

15. Basturk O, Hong SM, Maitra A, Esposito I, Kloppel G, Fukushima N, Maitra A, Furukawa T, Zamboni G. Pancreatic intraductal tubulopapillary neoplasm. In: WHO Classification of Tumours of the Digestive System. 5th Ed. WHO Classification of Tumours Editorial Board. (Ed), International Agency for Research on Cancer, Lyon, France, 2019.

14. Basturk O, Hong SM, Maitra A, Esposito I, Kloppel G, Fukushima N, Maitra A, Furukawa T, Zamboni G. Pancreatic intraductal oncocytic papillary neoplasm. In: WHO Classification of Tumours of the Digestive System. 5th Ed. WHO Classification of Tumours Editorial Board. (Ed), International Agency for Research on Cancer, Lyon, France, 2019.

13. Basturk O, Hong SM, Maitra A, Esposito I, Kloppel G, Fukushima N, Maitra A, Furukawa T, Zamboni G. Pancreatic intraductal oncocytic papillary neoplasm. In: WHO Classification of Tumours of the Digestive System. 5th Ed. WHO Classification of Tumours Editorial Board. (Ed), International Agency for Research on Cancer, Lyon, France, 2019.

12. Basturk O, Hong SM, Maitra A, Esposito I, Kloppel G, Fukushima N, Maitra A, Furukawa T, Zamboni G. Pancreatic intraductal papillary mucious neoplasm. In: WHO Classification of Tumours of the Digestive System. 5th Ed. WHO Classification of Tumours Editorial Board. (Ed), International Agency for Research on Cancer, Lyon, France, 2019.

11. Basturk O, Hong SM, Maitra A, Esposito I, Kloppel G, Fukushima N, Maitra A, Furukawa T, Zamboni G. Pancreatic intraepithelial neoplasia. In: WHO Classification of Tumours of the Digestive System. 5th Ed. WHO Classification of Tumours Editorial Board. (Ed), International Agency for Research on Cancer, Lyon, France, 2019.

10. Stelow EB and Hong SM. Gallbladder and Extrahepatic Biliary System. In: Histology for Pathologists. 5th Ed. Mills SE. (Ed), Wolters Kluwer, Philadelphia, PA, USA, 2019.

9. Hong SM. Biopsy, Bile, and Pancreatic Juice Tests. In: Hepato-Biliary-Pancreatic Surgery. 4th Ed. Kim SH, Suh KS, Lee KW, Jang JY. (Ed), Medrang. Seoul, Korea, (Korean), 2019.

8. Hong SM. Pathology of Autoimmune Pancreatitis. In: Textbook of the Pancreatology. 1st Ed. Chung JB. (Ed), Koonja Publishing, Seoul, Korea, (Korean), 2018.

Hong- 10

7. Hong SM. Pancreas Pathology of the Endocrine Pahncreas. In: Textbook of Endocrine Surgery. 2nd Ed. Korean Association of Thyorid and Endocrine Surgeons. Koonja Publishing, Seoul, Korea, (Korean), 2018.

6. Kim HK, Jang KT, Hur B, Hong SM. Disorder of the Pancreas. In Textbook of Pathology. 8th Ed. Korean Society of Pathologists. Komoonsa. Seoul, Korea, (Korean), 2017.

5. Jun SY, Hong SM. Nonductal Pancreatic Cancers. In: Pancreatic Pathology, An Issue of Surgical Pathology Clinics, 1st Ed. Wood L and Brosens L (Ed), Elsevier, New York, NY, USA, 2017.

4. Hong SM. Biopsy, Bile, and Pancreatic Juice Tests. In: Hepato-Biliary-Pancreatic Surgery. 3rd Ed. Kim SH and Suh KS. (Ed), Medrang. Seoul, Korea, (Korean), 2013.

3. Stelow EB, Hong SM, Frierson HF Jr. Gallbladder and Extrahepatic Biliary System. In: Histology for Pathologists. 4th Ed. Mills SE. (Ed), Lippincott Williams & Wilkins, Philadelphia, PA, USA, 2012.

2. Hong SM, Zaika AI. Extrahepatic bile duct carcinoma: role of p53 protein family. In: Methods of cancer diagnosis, therapy, and prognosis: Liver cancer. Hayat MA. (Ed), Springer Verlag, New York, NY, USA, 2009.

1. Stelow EB, Hong SM, Frierson HF Jr. Gallbladder and Extrahepatic Biliary System. In: Histology for Pathologists. 3rd Ed. Mills SE. (Ed), Lippincott Williams & Wilkins, Philadelphia, PA, USA, 2007.

Peer Review Papers

* Hong SM1: Co-first author

* Hong SM2: Corresponding author

262. Kim HD, Park S, Jeong S, Lee YJ, Lee H, Kim CG, Kim KH, Hong SM, Lee JY, Kim S, Kim HK, Min BS, Chang JH, Ju YS, Shin EC, Song GW, Hwang S, Park SH. 4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8+ T cells in Hepatocellular Carcinoma. Hepatology. 2019 Jul 28. doi: 10.1002/hep.30881. [Epub ahead of print] PMID: 31353502 261. Kim H, An S, Lee K, Ahn S, Park DY, Kim JH, Kang DW, Kim MJ, Chang MS, Jung ES,

Kim JM, Choi YJ, Jin SY, Chang HK, Cho MY, Kang YK, Kang M, Ahn S, Kim YW, Hong SM2; Gastrointestinal Pathology Study Group of the Korean Society of Pathologists. Pancreatic High-Grade Neuroendocrine Neoplasms in the Korean Population: A Multicenter Study. Cancer Res Treat. 2019 Jul 12. doi: 10.4143/crt.2019.192. [Epub ahead of print] PMID: 31319641 260. Springer S, Masica DL, Dal Molin M, Douville C, Thoburn CJ, Afsari B, Li L, Cohen JD, Thompson E, Allen PJ, Klimstra DS, Schattner MA, Schmidt CM, Yip-Schneider M, Simpson RE, Fernandez-Del Castillo C, Mino-Kenudson M, Brugge W, Brand RE, Singhi AD, Scarpa A,

Lawlor R, Salvia R, Zamboni G, Hong SM, Hwang DW, Jang JY, Kwon W, Swan N, Geoghegan J, Falconi M, Crippa S, Doglioni C, Paulino J, Schulick RD, Edil BH, Park W,

Hong- 11

Yachida S, Hijioka S, van Hooft J, He J, Weiss MJ, Burkhart R, Makary M, Canto MI, Goggins MG, Ptak J, Dobbyn L, Schaefer J, Sillman N, Popoli M, Klein AP, Tomasetti C, Karchin R, Papadopoulos N, Kinzler KW, Vogelstein B, Wolfgang CL, Hruban RH, Lennon AM. A multimodality test to guide the management of patients with a pancreatic cyst. Sci Transl Med. 2019 Jul 17;11(501). pii: eaav4772. doi: 10.1126/scitranslmed.aav4772. PMID: 31316009

259. Oh D, Seo DW, Hong SM, Song TJ, Park DH, Lee SS, Lee SK, Kim MH. The impact of macroscopic on-site evaluation using filter paper in EUS-guided fine-needle biopsy. Endosc Ultrasound. 2019 Jul 1. doi: 10.4103/eus.eus_34_19. [Epub ahead of print] PMID: 31268010

258. Jeun M, Lee HJ, Park S, Do EJ, Choi J, Sung YN, Hong SM, Kim SY, Kim DH, Kang JY, Son HN, Joo J, Song EM, Hwang SW, Park SH, Yang DH, Ye BD, Byeon JS, Choe J, Yang SK, Moinova H, Markowitz SD, Lee KH, Myung SJ. A Novel Blood-Based Colorectal Cancer Diagnostic Technology Using Electrical Detection of Colon Cancer Secreted Protein-2. Adv Sci (Weinh). 2019 Apr 16;6(11):1802115. doi: 10.1002/advs.201802115. eCollection 2019 Jun 5. PMID: 31179210

257. Jung SH, Jun SY, Shin S, Hong SM, Song SY, Yoo NJ, Chung YJ, Lee SH. Analysis of driver somatic mutations in heterotopia of pancreas, spleen, liver and adrenal tissues. Pathol Res Pract. 2019 Jul;215(7):152461. doi: 10.1016/j.prp.2019.152461. Epub 2019 May 23. No abstract available. PMID: 31146978 256. An S, Kim MJ, Kim SJ, Sung YN, Kim YW, Song KB, Hwang DW, Kim SC, Hruban RH,

Hong SM2. Multiple KRAS Mutations in the Non-Mucinous Epithelial Lining in the Majority of Mucinous Cystic Neoplasms of the Pancreas. Histopathology. 2019 May 11. doi: 10.1111/his.13897. [Epub ahead of print] PMID: 31077597

255. Song IH, Hong SM, Yu E, Yoon YS, Park IJ, Lim SB, Kim JC, Yu CS, Kim J. Pathology. Signet ring cell component predicts aggressive behaviour in colorectal mucinous adenocarcinoma. 2019 Jun;51(4):384-391. doi: 10.1016/j.pathol.2019.03.001. Epub 2019 Apr 24. PMID: 31029443

254. Cho E, Park IJ, Hong SM, Lee JL, Kim CW, Yoon YS, Lim SB, Yu CS, Kim JC. Poorer Oncologic Outcome of Good Responders to PCRT With Remnant Lymph Nodes Defies the Oncologic Paradox in Patients With Rectal Cancer. Clin Colorectal Cancer. 2019 Jun;18(2):e171-e178. doi: 10.1016/j.clcc.2019.03.003. Epub 2019 Apr 2. PMID: 31027968

253. Lee HG, Kim SJ, Park IJ, Hong SM, Lim SB, Lee JB, Yu CS, Kim JC. Effect of Responsiveness of Lymph Nodes to Preoperative Chemoradiotherapy in Patients With Rectal Cancer on Prognosis After Radical Resection. Clin Colorectal Cancer. 2019 Jun;18(2):e191-e199. doi: 10.1016/j.clcc.2019.03.001. Epub 2019 Apr 1. PMID: 31014994

252. Oh D, Song TJ, Moon SH, Kim JH, Lee JN, Hong SM, Lee JS, Jo SJ, Cho DH, Park DH, Lee SS, Seo DW, Lee SK, Kim MH. Type 2 Autoimmune Pancreatitis (Idiopathic Duct-Centric Pancreatitis) Highlighting Patients Presenting as Clinical Acute Pancreatitis: A SingleCenter Experience. Gut Liver. Gut Liver. 2019 Apr 17;13(4):461-470. doi: 10.5009/gnl18429. PMID: 30970429

251. Tomioka Y, Sung YN, Sawada R, Hong SM, Akita M, Itoh T, Ajiki T, Fukumoto T, Zen Y. IL-33 overexpression in gallbladder cancers associated with pancreatobiliary maljunction.

Hong- 12

Histopathology. 2019 Mar 18. doi: 10.1111/his.13863. [Epub ahead of print] PMID: 30882917

250. Park Y, Hwang DW, Kim JH, Hong SM, Jun SY, Lee JH, Song KB, Jun ES, Kim SC, Park KM. J Prognostic Comparison of the Longitudinal Margin Status in Distal Bile Duct Cancer: R0 on First Bile Duct Resection vs. R0 after Additional Resection. J Hepatobiliary Pancreat Sci. 2019 May;26(5):169-178. doi: 10.1002/jhbp.619. Epub 2019 Apr 8.PMID: 30849218

249. Hruban RH, Gaida MM, Thompson E, Hong SM, Nöe M, Brosens LAA, Jongepier M, Offerhaus GJA, Wood LD. Why is Pancreatic Cancer so Deadly? The Pathologist's View. J Pathol. 2019 Jun;248(2):131-141. doi: 10.1002/path.5260. Epub 2019 Apr 15.PMID: 30838636

248. Kang HJ, Haq F, Sung CO, Choi J, Hong SM, Eo SH, Jeong HJ, Shin J, Shim JH, Lee HC, An J, Kim MJ, Kim KP, Ahn SM, Yu E. Characterization of Hepatocellular Carcinoma Patients with FGF19 Amplification Assessed by Fluorescence in situ Hybridization: A Large Cohort Study. Liver Cancer. 2019 Feb;8(1):12-23. doi: 10.1159/000488541. Epub 2018 May 22. PMID: 30815392 247. Kim SJ, Kim MJ, Han JS, Sung YN, An S, Lee JH, Song KB, Hwang DW, Lee SS, Cho H,

Kim SC, Eshleman JR, Hong SM2. Prediction of Recurrence With KRAS Mutational Burden Using Ultrasensitive Digital Polymerase Chain Reaction of Radial Resection Margin of Resected Pancreatic Ductal Adenocarcinoma. Pancreas. 2019 Mar;48(3):400-411. doi: 10.1097/MPA.0000000000001255. PMID: 30747828

246. Jeong SA, Park IJ, Hong SM, Bong JW, Choi HY, Seo JH, Kim HE, Lim SB, Yu CS, Kim JC. Does total regression of primary rectal cancer after preoperative chemoradiotherapy represent "no tumor" status? Ann Surg Treat Res. 2019 Feb;96(2):78-85. doi: 10.4174/astr.2019.96.2.78. Epub 2018 Jan 30. PMID: 30746355

245. Choe J, Kim KW, Kim HJ, Kim DW, Kim KP, Hong SM, Ryu JS, Tirumani SH, Krajewski K, Ramaiya N. What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Neoplasms? Korean J Radiol. 2019 Jan;20(1):5-17. doi: 10.3348/kjr.2018.0040. Epub 2018 Dec 27. Review. PMID: 30627018

244. Kim SW, Kim J, Hong SM, Yoon YS, Park IJ, Yu CS, Kim J. Detailed Pathological Analysis of the Advancing Edge of the Tumor Can Effectively Stratify Clinical T4b Colorectal Cancer Patients. Histopathology. 2019 May;74(6):883-891. doi: 10.1111/his.13820. Epub 2019 Apr 1. PMID: 30609091

243. Haq F, Sung YN, Park I, Kayani MA, Yousuf F, Hong SM2, Ahn SM. FGFR1 expression defines clinically distinct subtypes in pancreatic cancer. J Transl Med. 2018 Dec 28;16(1):374. doi: 10.1186/s12967-018-1743-9. PMID: 30593273

242. Kang J, Yoo C, Hwang HS, Hong SM, Kim KP, Kim SY, Hong YS, Kim TW, Ryoo BY. Efficacy and safety of lanreotide in Korean patients with metastatic, well-differentiated gastroenteropancreatic-neuroendocrine tumors: a retrospective analysis. Invest New Drugs. 2018 Dec 10. doi: 10.1007/s10637-018-0710-x. [Epub ahead of print] PMID: 30536151 241. Chung SJ, König IR, Lohmann K, Hinrichs F, Kim J, Ryu HS, Lee HJ, Kim K, Lee JH, Jung

KW, Kim MJ, Kim MJ, Kim YJ, Yun SC, Hong SM, Myung SJ, Klein C. Association of SNCA variants with α-synuclein of gastric and colonic mucosa in Parkinson's disease. Parkinsonism

Hong- 13

Relat Disord. 2019 Apr;61:151-155. doi: 10.1016/j.parkreldis.2018.10.028. Epub 2018 Oct 26. PMID: 30424941

240. Kim MJ, Song TJ, Kim HJ, Kim SC, Kim MH, Hong SM2. Coexisting Mucinous Cystic Neoplasm of the Pancreas and Type 1 Autoimmune Pancreatitis. J Pathol Transl Med. 2019 Mar;53(2):125-128. doi: 10.4132/jptm.2018.10.25. Epub 2018 Nov 14. PMID: 30424589

239. Song JS, Yi JM, Cho H, Choi CH, Park Y, Chung EJ, Song J, Chung JY, Hong SM2. Dual loss of USP10 and p14ARF protein expression is associated with poor prognosis in patients with small intestinal adenocarcinoma. Tumour Biol. 2018 Oct;40(10):1010428318808678. doi: 10.1177/1010428318808678. PMID: 30375264

238. Kim JY, Hong SM 2. Precursor Lesions of Pancreatic Cancer. Oncol Res Treat. 2018;41(10):603-610. doi: 10.1159/000493554. Epub 2018 Sep 28. PMID: 30269131 237. Jeong BK, Sung YN, Kim SJ, An S, Park H, Hwang HS, Kang HJ, Lee JH, Song KB, Kim

KP, Hwang DW, Lee SS, Kim SC, Hong SM 2. High-grade precursor lesions can be used as surrogate markers to identify the epicenter of periampullary carcinomas. Hum Pathol. 2019 Feb;84:92-104. doi: 10.1016/j.humpath.2018.09.006. Epub 2018 Sep 24 PMID: 30261192

236. Hong SM, Noë M, Hruban CA, Thompson ED, Wood LD, Hruban RH. A "Clearer" View of Pancreatic Pathology: A Review of Tissue Clearing and Advanced Microscopy Techniques. Adv Anat Pathol. 2019 Jan;26(1):31-39. doi: 10.1097/PAP.0000000000000215. PMID: 30256228

235. Hong SB, Lee SS, Kim JH, Kim HJ, Byun JH, Hong SM, Song KB, Kim SC. Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria. Radiology. 2018 Dec;289(3):710-718. doi: 10.1148/radiol.2018180628. Epub 2018 Sep 25. PMID: 30251929 234. Hwang HS, Kim Y, An S, Kim SJ, Kim JY, Kim SY, Hwang DW, Park DH, Lee SS, Kim SC,

Seo DW, Hong SM 2. Grading by the Ki-67 Labeling Index of Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy Specimens of Pancreatic Neuroendocrine Tumors Can Be Underestimated. Pancreas. 2018 Nov/Dec;47(10):1296-1303. doi: 10.1097/MPA.0000000000001157. PMID: 30211805 233. Kim HD, Song GW, Park S, Jung MK, Kim MH, Kang HJ, Yoo C, Yi K, Kim KH, Eo S,

Moon DB, Hong SM, Ju YS, Shin EC, Hwang S, Park SH. Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma. Gastroenterology. 2018 Dec;155(6):1936-1950.e17. doi: 10.1053/j.gastro.2018.08.030. Epub 2018 Aug 24. PMID: 30145359

232. Kwon JH, Kim HJ, Park DH, Lee YJ, Heaphy CM, Klöppel G, Hruban RH, Hong SM 2. Incidentally detected pancreatic neuroendocrine microadenoma with lymph node metastasis. Virchows Arch. 2018 Nov;473(5):649-653. doi: 10.1007/s00428-018-2407-0. Epub 2018 Jul 12. PMID: 30003325

231. Lee HJ, Jung KW, Chung SJ, Hong SM, Kim J, Lee JH, Hwang SW, Ryu HS, Kim MJ, Lee HS, Seo M, Park SH, Yang DH, Ye BD, Byeon JS, Choe J, Jung HY, Yang SK, Myung SJ. Relation of Enteric α-Synuclein to Gastrointestinal Dysfunction in Patients With Parkinson's Disease and in Neurologically Intact Subjects. J Neurogastroenterol Motil. 2018 Jul 30;24(3):469-478. doi: 10.5056/jnm17141. PMID: 29969861

Hong- 14

230. Park HJ, Kim HJ, Park SH, Lee JS, Kim AY, Kim SW, Hong SM. JOURNAL CLUB: Primary Anorectal Melanoma: MRI Findings and Clinicopathologic Correlations. AJR Am J Roentgenol. 2018 Aug;211(2):W98-W108. doi: 10.2214/AJR.17.18807. Epub 2018 Jun 21. PMID: 29927334

229. Oh D, Seo DW, Hong SM, Jun JH, Song TJ, Park DH, Son BK, Lee SS, Lee SK, Kim MH. The usefulness of contrast-enhanced harmonic EUS-guided fine-needle aspiration for evaluation of hepatic lesions (with video). Gastrointest Endosc. 2018 Sep;88(3):495-501. doi: 10.1016/j.gie.2018.05.019. Epub 2018 May 31. PMID: 29859228

228. Kwon JH, Kim JH, Kim SY, Byun JH, Kim HJ, Hong SM, Lee MG, Lee SS. Imaging and clinical features of xanthogranulomatous pancreatitis: an analysis of 10 cases at a single institution. Abdom Radiol (NY). 2018 Dec;43(12):3349-3356. doi: 10.1007/s00261-018-1630-0. PMID: 29725744

227. Noë M, Rezaee N, Asrani K, Skaro M, Groot VP, Wu PH, Olson MT, Hong SM, Kim SJ, Weiss MJ, Wolfgang CL, Makary MA, He J, Cameron JL, Wirtz D, Roberts NJ, Offerhaus GJA, Brosens LAA, Wood LD, Hruban RH. Immunolabeling of Cleared Human Pancreata Provides Insights into Three-dimensional Pancreatic Anatomy and Pathology. Am J Pathol. 2018 Jul;188(7):1530-1535. doi: 10.1016/j.ajpath.2018.04.002. Epub 2018 Apr 22. PMID: 29684363

226. Kim JY, Lee SH, An S, Kim SJ, Sung YN, Song KB, Hwang DW, Kim SC, Hong SM 2. Carbonic anhydrase 9 expression in well-differentiated pancreatic neuroendocrine neoplasms might be associated with aggressive behavior and poor survival. Virchows Arch. 2018 May;472(5):739-748. doi: 10.1007/s00428-018-2353-x. Epub 2018 Apr 18. PMID: 29666945 225. Yokode M, Akita M, Fujikura K, Kim MJ, Morinaga Y, Yoshikawa S, Terada T, Matsukiyo

H, Tajiri T, Abe-Suzuki S, Itoh T, Hong SM2, Zen Y. High-grade PanIN presenting with localized stricture of the main pancreatic duct: A clinicopathological and molecular study of 10 cases suggests a clue for the early detection of pancreatic cancer. Histopathology. 2018 Aug;73(2):247-258. doi: 10.1111/his.13629. Epub 2018 May 30. PMID: 29660164

224. Park HJ, Kim SY, Kim HJ, Lee SS, Hong GS, Byun JH, Hong SM, Lee MG. Intraductal Papillary Neoplasm of the Bile Duct: Clinical, Imaging, and Pathologic Features. AJR Am J Roentgenol. 2018 Jul;211(1):67-75. doi: 10.2214/AJR.17.19261. Epub 2018 Apr 9. PMID: 29629808 223. Kang J, Hwang I, Yoo C, Kim KP, Jeong JH, Chang HM, Lee SS, Park DH, Song TJ, Seo

DW, Lee SK, Kim MH, Hong SM, Shin SH, Hwang DW, Song KB, Lee JH, Kim SC, Ryoo BY. Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis. Invest New Drugs. 2018 Aug;36(4):732-741. doi: 10.1007/s10637-018-0598-5. Epub 2018 Apr 3. PMID: 29616439

222. Choi JH, Park DH, Kim MH, Hwang HS, Hong SM, Song TJ, Lee SS, Seo DW, Lee SK. Outcomes after endoscopic ultrasound-guided ethanol-lipiodol ablation of small pancreatic neuroendocrine tumors. Dig Endosc. 2018 Sep;30(5):652-658. doi: 10.1111/den.13058. Epub 2018 Apr 19. PMID: 29575213 221. Jun SY, Hong SM, Bae YK, Kim HK, Jang KY, Eom DW. Clinicopathological and prognostic significance of heme oxygenase-1 expression in small intestinal adenocarcinomas. Pathol Int. 2018 May;68(5):294-300. doi: 10.1111/pin.12657. Epub 2018 Mar 14. PMID:

Hong- 15

29537718

220. Jun SY, Sung YN, Lee JH, Park KM, Lee YJ, Hong SM.2 Validation of the eighth American Joint Committee on Cancer Staging System for Distal Bile Duct Carcinoma. Cancer Res Treat. 2019 Jan;51(1):98-111. doi: 10.4143/crt.2017.595. Epub 2018 Mar 2. PMID: 29510611

219. Jun E, Hong SM, Yoo HJ, Kim MB, Won JS, An S, Shim IK, Chang S, Hoffman RM, Kim SC. Genetic and metabolic comparison of orthotopic and heterotopic patient-derived pancreatic-cancer xenografts to the original patient tumors. Oncotarget. 2017 Dec 21;9(8):7867-7881. doi: 10.18632/oncotarget.23567. eCollection 2018 Jan 30. PMID: 29487698

218. Park JY, Lee JH, Song KB, Hwang DW, Kim KR, Kim SC, Hong SM.2 Significance of microcystic, elongated, and fragmented glandular-like features in intraductal papillary mucinous neoplasm of the pancreas. Hum Pathol. 2018 Aug;78:18-27. doi: 10.1016/j.humpath.2018.01.020. Epub 2018 Feb 2. PMID: 29410139 217. Kim SJ, An S, Kang HJ, Kim JY, Jang MA, Lee JH, Song KB, Hwang DW, Cho H, Kim SC,

Yu E, Hong SM.2 Validation of the eighth edition of the American Joint Committee on Cancer staging system for ampulla of Vater cancer. Surgery. 2018 May;163(5):1071-1079. doi: 10.1016/j.surg.2017.12.018. Epub 2018 Feb 13.PMID: 29452703

216. Kim SJ, Akita M, Sung YN, Fujikura K, Lee JH, Hwang S, Yu E, Otani K, Hong SM 2, Zen Y. MDM2 Amplification in Intrahepatic Cholangiocarcinomas: Its Relationship With Large-Duct Type Morphology and Uncommon KRAS Mutations. Am J Surg Pathol. 2018 Apr;42(4):512-521. doi: 10.1097/PAS.0000000000001006. PMID: 29309301

215. Nakanuma Y, Jang KT, Fukushima N, Furukawa T, Hong SM, Kim H, Lee KB, Zen Y, Jang JY, Kubota K. A statement by the Japan-Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stage. J Hepatobiliary Pancreat Sci. 2018 Mar;25(3):181-187. doi: 10.1002/jhbp.532. Epub 2018 Feb 12.PMID: 29272078 214. Shin SJ, Park H, Sung YN, Yoo C, Hwang DW, Park JH, Kim KP, Lee SS, Ryoo BY, Seo

DW, Kim SC, Hong SM 2. Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only. Cancer Res Treat. 2018 Oct;50(4):1175-1185. doi: 10.4143/crt.2017.494. Epub 2017 Dec 20. PMID: 29268568

213. Kim JS, Kim HJ, Hong SM, Park SH, Lee JS, Kim AY, Ha HK. Post-Ischemic Bowel Stricture: CT Features in Eight Cases. Korean J Radiol. 2017 Nov-Dec;18(6):936-945. doi: 10.3348/kjr.2017.18.6.936. Epub 2017 Sep 21. PMID: 29089826 212. Hong SA, Sung YN, Kim HJ, Lee SS, Lee JH, Ahn CS, Hwang S, Yu E, Zen Y, Kim MH,

Hong SM 2. Xanthogranulomatous cholecystitis exhibits overlapping histologic features with IgG4-related cholecystitis. Histopathology. 2018 Mar;72(4):569-579. doi: 10.1111/his.13413. Epub 2017 Dec 14. PMID: 29023932

211. Kim J, Do EJ, Moinova H, Bae SM, Kang JY, Hong SM, Fink SP, Joo J, Suh YA, Jang SJ, Hwang SW, Park SH, Yang DH, Ye BD, Byeon JS, Choe J, Yang SK, Markowitz SD, Kim SY,

Hong- 16

Myung SJ. Molecular Imaging of Colorectal Tumors by Targeting Colon Cancer Secreted Protein-2 (CCSP-2). Neoplasia. 2017 Oct;19(10):805-816. doi: 10.1016/j.neo.2017.07.003. Epub 2017 Sep 5. PMID: 28886423 210. Cohen JD, Javed AA, Thoburn C, Wong F, Tie J, Gibbs P, Schmidt CM, Yip-Schneider

MT, Allen PJ, Schattner M, Brand RE, Singhi AD, Petersen GM, Hong SM, Kim SC, Falconi M, Doglioni C, Weiss MJ, Ahuja N, He J, Makary MA, Maitra A, Hanash SM, Dal Molin M, Wang Y, Li L, Ptak J, Dobbyn L, Schaefer J, Silliman N, Popoli M, Goggins MG, Hruban RH, Wolfgang CL, Klein AP, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Lennon AM. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers. Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10202-10207. doi: 10.1073/pnas.1704961114. Epub 2017 Sep 5. PMID: 28874546

209. Shin SH, Park SS, Lee KJ, Ju EJ, Park J, Ko EJ, Jung J, Kuroda S, Hong SM, Hwang JJ, Lee JS, Song SY, Jeong SY, Choi EK. Preclinical evaluation of cisplatin-incorporated bio-nanocapsules as chemo-radiotherapy for human hepatocellular carcinoma. Oncol Rep. 2017 Oct;38(4):2259-2266. doi: 10.3892/or.2017.5910. Epub 2017 Aug 21.PMID: 28849069

208. Kim JY, Hong SM, Ro JY. Recent updates on grading and classification of neuroendocrine tumors. Ann Diagn Pathol. 2017 Aug;29:11-16. doi: 10.1016/j.anndiagpath.2017.04.005. Epub 2017 Apr 13. Review. PMID: 28807335 207. Basturk O, Berger MF, Yamaguchi H, Adsay V, Askan G, Bhanot UK, Zehir A, Carneiro F,

Hong SM, Zamboni G, Dikoglu E, Jobanputra V, Wrzeszczynski KO, Balci S, Allen P, Ikari N, Takeuchi S, Akagawa H, Kanno A, Shimosegawa T, Morikawa T, Motoi F, Unno M, Higuchi R, Yamamoto M, Shimizu K, Furukawa T, Klimstra DS. Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma. 2017 Dec;30(12):1760-1772. doi: 10.1038/modpathol.2017.60. Epub 2017 Aug 4. PMID: 28776573

206. Park IJ, An S, Kim SY, Lim HM, Hong SM, Kim MJ, Kim YJ, Yu CS. Prediction of radio-responsiveness with immune-profiling in patients with rectal cancer. Oncotarget. 2017 Jul 25;8(45):79793-79802. doi: 10.18632/oncotarget.19558. eCollection 2017 Oct 3. PMID: 28762952

205. Lee KJ, Shin SH, Lee JH, Ju EJ, Park YY, Hwang JJ, Suh YA, Hong SM, Jang SJ, Lee JS, Song SY, Jeong SY, Choi EK. A strategy for actualization of active targeting nanomedicine practically functioning in a living body. Biomaterials. 2017 Oct;141:136-148. doi: 10.1016/j.biomaterials.2017.06.037. Epub 2017 Jun 30. PMID: 28688285

204. Seo S, Yoo C, Kim KP, Ryoo BY, Chang HM, Hong SM, Lee JH, Song KB, Hwang DW, Kim KH, Hwang S, Kim SC. Clinical Outcomes of Patients with Resectable Pancreatic Acinar Cell Carcinoma. J Dig Dis. 2017 Aug;18(8):480-486. doi: 10.1111/1751-2980.12505. PMID: 28671770

203. Kim C, Byun JH, Hong SM, An S, Kim JH, Lee SS, Kim HJ. A comparison of enhancement patterns on dynamic enhanced CT and survival between patients with pancreatic neuroendocrine tumors with and without intratumoral fibrosis. Abdom Radiol (NY 2017 Dec;42(12):2835-2842. doi: 10.1007/s00261-017-1212-6. PMID: 28624923

202. Ku Y, Hong SM, Fujikura K, Kim SJ, Akita M, Abe-Suzuki S, Shiomi H, Masuda A, Itoh T,

Hong- 17

Azuma T, Kim MH, Zen Y. IL-8 Expression in Granulocytic Epithelial Lesions of Idiopathic Duct-centric Pancreatitis (Type 2 Autoimmune Pancreatitis). Am J Surg Pathol. 2017 Aug;41(8):1129-1138. doi: 10.1097/PAS.0000000000000891. PMID: 28614208

201. Kim SJ, An S, Lee JH, Kim JY, Song KB, Hwang DW, Kim SC, Yu E, Hong SM 2. Loss of Progesterone Receptor Expression Is an Early Tumorigenesis Event Associated with Tumor Progression and Shorter Survival in Pancreatic Neuroendocrine Tumor Patients. J Pathol Transl Med. 2017 Jul;51(4):388-395. doi: 10.4132/jptm.2017.03.19. Epub 2017 Jun 8. PMID: 28597868

200. Handra-Luca A, Ngo A, Hong SM. Perivesical cystic duct of the gallbladder. Surg Radiol Anat. 2017 Dec;39(12):1401-1403. doi: 10.1007/s00276-017-1869-0. Epub 2017 May 10. No abstract available. PMID: 28493009

199. Yoo C, Kang J, Kim D, Kim KP, Ryoo BY, Hong SM, Hwang JJ, Jeong SY, Hwang S, Kim KH, Lee YJ, Hoeflich KP, Schmidt-Kittler O, Miller S, Choi EK. Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma. Oncotarget. 2017 Jun 13;8(24):38592-38601. doi: 10.18632/oncotarget.16951. PMID: 28445152

198. Kim KJ, Kim JY, Hong SM, Gu MJ. Loss of CADM4 expression is associated with poor prognosis in small intestinal adenocarcinomas. APMIS. 2017 May;125(5):437-443. doi: 10.1111/apm.12684. PMID: 28444978

197. Oh D, Seo DW, Hong SM, Song TJ, Park DH, Lee SS, Lee SK, Kim MH. Endoscopic ultrasound-guided fine-needle aspiration can target right liver mass. Endosc Ultrasound. 2017 Mar-Apr;6(2):109-115. doi: 10.4103/2303-9027.204813. PMID: 28440236 196. Kim MJ, Kim MS, Kim SJ, An S, Park J, Park H, Lee JH, Song KB, Hwang DW, Chang S,

Kim KP, Jeong SY, Kim SC, Hong SM 2. Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patients. Cancer Cell Int. 2017 Apr 20;17:47. doi: 10.1186/s12935-017-0416-8. eCollection 2017. PMID: 28435405

195. Luchini C, Robertson SA, Hong SM, Felsenstein M, Anders RA, Pea A, Nottegar A, Veronese N, He J, Weiss MJ, Capelli P, Scarpa A, Argani P, Kapur P, Wood LD. PBRM1 loss is a late event during the development of cholangiocarcinoma. Histopathology. 2017 Sep;71(3):375-382. doi: 10.1111/his.13234. Epub 2017 Jun 22. PMID: 28394406 194. Jun SY, Son D, Kim MJ, Kim SJ, An S, Park YS, Park SR, Choi KD, Jung HY, Kim SC,

Yook JH, Kim BS, Hong SM2. Heterotopic Pancreas of the Gastrointestinal Tract and Associated Precursor and Cancerous Lesions: Systematic Pathologic Studies of 165 Cases. Am J Surg Pathol. 2017 Jun;41(6):833-848. doi: 10.1097/PAS.0000000000000850. PMID: 28368927

193. Choi SH, Kim HJ, Kim KW, An S, Hong SM, Kim SC, Kim MH. DPC4 gene expression in primary pancreatic ductal adenocarcinoma: Relationship with CT characteristics. Br J Radiol. 2017 May;90(1073):20160403. doi: 10.1259/bjr.20160403. Epub 2017 Mar 24. PMID: 28339284

192. Jun E, Kim SC, Song KB, Hwang DW, Lee JH, Shin SH, Hong SM, Park KM, Lee YJ. Diagnostic value of chromogranin A in pancreatic neuroendocrine tumors depends on tumor

Hong- 18

size: A prospective observational study from a single institute. Surgery. 2017 Jul;162(1):120-130. doi: 10.1016/j.surg.2017.01.019. Epub 2017 Mar 2.PMID: 28262254 191. Jun SY, Lee EJ, Kim MJ, Chun SM, Bae YK, Uk Hong S, Choi J, Kim JM, Jang KT, Kim

JY, Il Kim G, Jung SJ, Yoon G, Hong SM2. Lynch syndrome-related small intestinal adenocarcinomas. Oncotarget. 2017 Mar 28;8(13):21483-21500. doi: 10.18632/oncotarget.15277. PMID: 28206961

190. Jang S, Hong M, Shin MK, Kim BC, Shin HS, Yu E, Hong SM, Kim J, Chun SM, Kim TI, Choi KC, Ko YW, Kim JW. KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behavior. Hum Pathol. 2017 Jul;65:21-30. doi: 10.1016/j.humpath.2017.01.010. Epub 2017 Feb 8. PMID: 28188750

189. Park S, Kim SC, Hong SM, Lee YJ, Park KM, Hwang DW, Lee JH, Song KB, Ryoo BY, Jang HM, Kim KP, Yu C, Choi EK, DO Ahn S, Lee SW, Yoon SM, Park JH, Kim JH. Postoperative Radiotherapy for Pancreatic Cancer with Microscopically-positive Resection Margin. Anticancer Res. 2017 Feb;37(2):755-764. PMID: 28179327

188. Shin SH, Kim HJ, Hwang DW, Lee JH, Song KB, Jun E, Shim IK, Hong SM, Kim HJ, Park KM, Lee YJ, Kim SC. The DPC4/SMAD4 genetic status determines recurrence patterns and treatment outcomes in resected pancreatic ductal adenocarcinoma: A prospective cohort study. Oncotarget. 2017 Mar 14;8(11):17945-17959. doi: 10.18632/oncotarget.14901.PMID: 28160547

187. Hata T, Dal Molin M, Hong SM, Tamura K, Suenaga M, Yu J, Sedogawa H, Weiss MJ, Wolfgang CL, Lennon AM, Hruban RH, Goggins MG. Predicting the grade of dysplasia of pancreatic cystic neoplasms using cyst fluid DNA methylation markers. Clin Cancer Res. 2017 Jul 15;23(14):3935-3944. doi: 10.1158/1078-0432.CCR-16-2244. Epub 2017 Feb 1. PMID: 28148542

186. Lee S, Choi KD, Hong SM, Park SH, Gong EJ, Na HK, Ahn JY, Jung KW, Lee JH, Kim DH, Song HJ, Lee GH, Jung HY, Kim JH. Pattern of extragastric recurrence and the role of abdominal computed tomography in surveillance after endoscopic resection of early gastric cancer: Korean experiences. Gastric Cancer. 2017 Jan 27. doi: 10.1007/s10120-017-0691-z. [Epub ahead of print] PMID: 28130712

185. Jung DH, Hwang S, Song GW, Ahn CS, Moon DB, Kim KH, Ha TY, Park GC, Hong SM, Kim WJ, Kang WH, Kim SH, Yu ES, Lee SG. Clinicopathological Features and Prognosis of Intrahepatic Cholangiocarcinoma After Liver Transplantation and Resection. Ann Transplant. 2017 Jan 26;22:42-52. PMID: 28123170

184. Jung DH, Hwang S, Hong SM, Kim KH, Ahn CS, Moon DB, Alshahrani AA, Lee SG. Clinico-pathological correlation of hepatic angiomyolipoma: a series of 23 resection cases. ANZ J Surg. 2018 Jan;88(1-2):E60-E65. doi: 10.1111/ans.13880. Epub 2017 Jan 25. PMID: 28122404

183. Kim KM, Kim CY, Hong SM, Jang KY. A primary pure pancreatic-type acinar cell carcinoma of the stomach: a case report. Diagn Pathol. 2017 Jan 19;12(1):10. doi: 10.1186/s13000-017-0601-z. PMID: 28103943

182. Choi JP, Kim SJ, Park IJ, Hong SM, Lee JL, Yoon YS, Kim CW, Lim SB, Lee JB, Yu CS, Kim JC. Is the pathological regression level of metastatic lymph nodes associated with

Hong- 19

oncologic outcomes following preoperative chemoradiotherapy in rectal cancer? Oncotarget. 2017 Feb 7;8(6):10375-10384. doi: 10.18632/oncotarget.14418. PMID: 28060748

181. Song KH, Woo SR, Chung JY, Lee HJ, Oh SJ, Hong SO, Shim J, Kim YN, Rho SB, Hong

SM, Cho H, Hibi M, Bae DJ, Kim SY, Kim MG, Kim TW, Bae YK. REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival. Cell Death Dis. 2017 Jan 5;8(1):e2536. doi: 10.1038/cddis.2016.462. PMID: 28055019

180. Handra-Luca A, Hong SM. Clin Anat. Mucosal nerve of the gallbladder: Anatomical variant or malformation? Clin Anat. 2017 Jul;30(5):558-559. doi: 10.1002/ca.22826. Epub 2017 Jan 18. No abstract available. PMID: 28035687

179. Jung DH, Hwang S, Hong SM, Kim KH, Lee YJ, Ahn CS, Moon DB, Ha TY, Song GW, Park GC, Yu E, Lee SG. Clinicopathological Features and Prognosis of Hepatic Epithelioid Hemangioendothelioma After Liver Resection and Transplantation. Ann Transplant. 2016 Dec 29;21:784-790. PMID: 28031549

178. Jung DH, Hwang S, Song GW, Ahn CS, Moon DB, Kim KH, Ha TY, Park GC, Hong SM, Kim WJ, Kang WH, Hwan Kim S, Yu ES, Lee SG. Long-term Prognosis of Combined Hepatocellular Carcinoma-Cholangiocarcinoma Following Liver Transplantation and Resection. Liver Transpl. 2017 Mar;23(3):330-341. doi: 10.1002/lt.24711. PMID: 28027599 177. Yoo C, Cho H, Song MJ, Hong SM, Kim KP, Chang HM, Chae H, Kim TW, Hong YS, Ryu MH, Kang YK, Kim SC, Ryoo BY. Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumor. Cancer Chemother Pharmacol. 2017 Jan;79(1):139-146. doi: 10.1007/s00280-016-3215-3. PMID: 27942928

176. Jun SY, Hong SM 2. Nonductal Pancreatic Cancers. Surg Pathol Clin. 2016 Dec;9(4):581-593. doi: 10.1016/j.path.2016.05.005. PMID: 27926361

175. Jung DH, Hwang S, Hong SM, Chung YK, Song GW, Lee YJ, Kim KH, Ahn CS, Moon DB, Ha TY, Park GC, Lee HC, Lim YS, Yu ES, Lee SG. Post-resection Prognosis of Combined Hepatocellular Carcinoma-Cholangiocarcinoma According to the 2010 WHO Classification. World J Surg. 2017 May;41(5):1347-1357. doi: 10.1007/s00268-016-3837-y. PMID: 27896409

174. Sakai Y, Hong SM 2, An S, Kim JY, Corbeil D, Karbanová J, Otani K, Fujikura K, Song KB, Kim SC, Akita M, Nanno Y, Toyama H, Fukumoto T, Ku Y, Hirose T, Itoh T, Zen Y. CD133 expression in well-differentiated pancreatic neuroendocrine tumors: A potential predictor of progressive clinical courses. Hum Pathol. 2017 Mar;61:148-157. doi: 10.1016/j.humpath.2016.10.022. Epub 2016 Nov 15. PMID: 27864124 173. Kim SW, Song IH, An S, Kim SY, Kim HJ, Song KB, Hwang DW, Lee SS, Byun JH, Seo

DW, Kim SC, Yu E, Hong SM 2. Pancreatic serous cystic neoplasms accompanying other pancreatic tumors. Hum Pathol. 2017 Feb;60:104-113. doi: 10.1016/j.humpath.2016.10.011. Epub 2016 Nov 2. PMID: 27816717

172. Jung DH, Hwang S, Kim KH, Hong SM, Lee YJ, Ahn CS, Moon DB, Ha TY, Song GW, Park GC, Yu ES, Lee SG. Clinicopathological Features and Post-resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. World J Surg. 2016 Nov 3. [Epub ahead of print] PMID: 27812807

Hong- 20

171. Choi SH, Lee SS, Kim SY, Park SH, Park SH, Kim KM, Hong SM, Yu E, Lee MG. Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Differentiation from Hepatocellular Carcinoma by Using Gadoxetic Acid-enhanced MR Imaging and Dynamic CT. Radiology. 2017 Mar;282(3):771-781. doi: 10.1148/radiol.2016160639. Epub 2016 Oct 31. PMID: 27797675

170. Lee SH, Kim JY, An S, Song KB, Hwang DW, Kim SC, Yu E, Hong SM2. Carbonic anhydrase 9 expression in pancreatic neuroendocrine tumors is associated with aggressive behavior. Pathology. 2016 Feb;48 Suppl 1:S138. doi: 10.1016/j.pathol.2015.12.374. No abstract available. PMID: 27772890

169. Kim JY, Brosnan-Cashman JA, An S, Kim SJ, Song KB, Kim MS, Kim MJ, Hwang DW,

Meeker AK, Yu E, Kim SC, Hruban RH, Heaphy CM, Hong SM 2. Alternative lengthening of telomeres in primary pancreatic neuroendocrine neoplasms is associated with aggressive clinical behavior and poor survival. 2017 Mar 15;23(6):1598-1606. doi: 10.1158/1078-0432.CCR-16-1147. Epub 2016 Sep 23. PMID: 27663587

168. Jung J, Lee HC, Seol HS, Choi YS, Kim E, Lee EJ, Rhee JK, Singh SR, Jun ES, Han B,

Hong SM, Kim SC, Chang S. Generation and molecular characterization of pancreatic cancer patient-derived xenografts reveals their heterologous nature. Oncotarget. 2016 Sep 20;7(38):62533-62546. doi: 10.18632/oncotarget.11530. PMID: 27613834

167. Huh J, Byun JH, Hong SM, Kim KW, Kim JH, Lee SS, Kim HJ, Lee MG. Malignant pancreatic serous cystic neoplasms: systematic review with a new case. BMC Gastroenterol. 2016 Aug 22;16(1):97. doi: 10.1186/s12876-016-0518-0. PMID: 27549181

166. Chung JY, Choi J, Sears JD, Ylaya K, Perry C, Choi CH, Hong SM, Cho H, Brown KM, Hewitt SM. A melanin-bleaching methodology for molecular and histopathological analysis of formalin-fixed paraffin-embedded tissue. Lab Invest. 2016 Oct;96(10):1116-27. doi: 10.1038/labinvest.2016.90. PMID: 27548802

165. Choi JP, Park IJ, Lee BC, Hong SM, Lee JL, Yoon YS, Kim CW, Lim SB, Lee JB, Yu CS, Kim JC. Variability in the lymph node retrieval after resection of colon cancer: Influence of operative period and process. Medicine (Baltimore). 2016 Aug;95(31):e4199. doi: 10.1097/MD.0000000000004199. PMID: 27495024

164. Seo H, Park SH, Byeon JS, Woo CG, Hong SM, Chang K, So H, Kwak M, Kim WS, Lee JM, Yang DH, Kim KJ, Ye BD, Myung SJ, Yang SK. Chronic intractable diarrhea caused by gastrointestinal mastocytosis. Intest Res. 2016 Jul;14(3):280-4. doi: 10.5217/ir.2016.14.3.280. PMID: 27433151

163. Kim KP, Kim JE, Hong YS, Ahn SM, Chun SM, Hong SM, Jang SJ, Yu CS, Kim JC, Kim TW. Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal Cancer. Cancer Res Treat. 2017 Jan;49(1):161-167. doi: 10.4143/crt.2015.490. Epub 2016 Jul 4. PMID: 27384156

162. Omura N, Mizuma M, MacGregor A, Hong SM, Ayars M, Borges M, Kanda M, Li A, Vincent A, Maitra A, Goggins M. Overexpression of ankyrin1 promotes pancreatic cancer cell growth. Oncotarget. 2016 Jun 7;7(23):34977-87. doi: 10.18632/oncotarget.9009. PMID: 27144336

Hong- 21

161. Kim JY, Hong SM2. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts. Arch Pathol Lab Med. 2016 May;140(5):437-48. doi: 10.5858/arpa.2015-0314-RA. PMID: 27128301

160. Jun SY, Kim M, Jin Gu M, Kyung Bae Y, Chang HK, Sun Jung E, Jang KT, Kim J, Yu E,

Woon Eom D, Hong SM2. Clinicopathologic and prognostic associations of KRAS and BRAF mutations in small intestinal adenocarcinoma. Mod Pathol. 2016 Apr;29(4):402-15. doi: 10.1038/modpathol.2016.40. Epub 2016 Feb 19. PMID: 26892442

159. Jun E, Jung J, Jeong SY, Choi EK, Kim MB, Lee JS, Hong SM, Seol HS, Hwang C, Hoffman RM, Shim IK, Chang S, Kim SC. Surgical and Oncological Factors Affecting the Successful Engraftment of Patient-derived Xenografts in Pancreatic Ductal Adenocarcinoma. Anticancer Res. 2016 Feb;36(2):517-21. PMID: 26851005

158. Hong GS, Byun JH, Kim JH, Kim HJ, Lee SS, Hong SM, Lee MG. Thread sign in biliary intraductal papillary mucinous neoplasm: a novel specific finding for MRI. Eur Radiol. 2016 Sep;26(9):3112-20. doi: 10.1007/s00330-015-4158-5. PMID: 26694060

157. Chung SJ, Kim J, Lee HJ, Ryu HS, Kim K, Lee JH, Jung KW, Kim MJ, Kim MJ, Kim YJ,

Yun SC, Lee JY, Hong SM2, Myung SJ. Alpha-synuclein in gastric and colonic mucosa in Parkinson's disease: Limited role as a biomarker. Mov Disord. 2016 Feb;31(2):241-9. doi: 10.1002/mds.26473. PMID: 26686342

156. Kim JY, Park IJ, Hong SM, Lee JL, Yoon YS, Kim CW, Lim SB, Lee JB, Yu CS, Kim JC. Is Pathologic Near-Total Regression an Appropriate Indicator of a Good Response to Preoperative Chemoradiotherapy Based on Oncologic Outcome of Disease? Medicine (Baltimore). 2015 Dec;94(50):e2257. doi: 10.1097/MD.0000000000002257. PMID: 26683945 155. Yoon YI, Hwang S, Lee YJ, Kim KH, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Lee

JW, Hong SM, Yu ES, Lee SG. Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. J Gastrointest Surg. 2016 Feb;20(2):411-20. doi: 10.1007/s11605-015-3045-3. Epub 2015 Dec 1. PMID: 26628072

154. Basturk O, Hong SM 1, Wood LD, Adsay NV, Albores-Saavedra J, Biankin AV, Brosens LA, Fukushima N, Goggins M, Hruban RH, Kato Y, Klimstra DS, Klöppel G, Krasinskas A, Longnecker DS, Matthaei H, Offerhaus GJ, Shimizu M, Takaori K, Terris B, Yachida S, Esposito I, Furukawa T. A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas. Am J Surg Pathol. 2015 Dec;39(12):1730-41. doi: 10.1097/PAS.0000000000000533. PMID: 26559377

153. Kang CM, Lim SB, Hong SM, Yu CS, Hong YS, Kim TW, Park JH, Kim JH, Kim JC. Prevalence and clinical significance of cellular and acellular mucin in locally advanced mucinous rectal cancer patients who underwent preoperative chemoradiotherapy followed by radical surgery. Colorectal Dis. 2016 Jan;18(1):O10-6. doi: 10.1111/codi.13169. PMID: 26530997

Hong- 22

152. Song KB, Kim SC, Kim JH, Seo DW, Hong SM, Park KM, Hwang DW, Lee JH, Lee YJ. Prognostic Value of Somatostatin Receptor Subtypes in Pancreatic Neuroendocrine Tumors. Pancreas. 2016 Feb;45(2):187-92. doi: 10.1097/MPA.0000000000000493. PMID: 26474434

151. Kang BK, Lee SS, Cheong H, Hong SM, Jang K, Lee MG. Shear Wave Elastography for Assessment of Steatohepatitis and Hepatic Fibrosis in Rat Models of Non-Alcoholic Fatty Liver Disease. Ultrasound Med Biol. 2015 Dec;41(12):3205-15. doi: 10.1016/j.ultrasmedbio.2015.07.025. Epub 2015 Sep 5. PMID: 26349582

150. Park HS, Kim SY, Hong SM, Park SH, Lee SS, Byun JH, Kim JH, Kim HJ, Lee MG. Hypervascular solid-appearing serous cystic neoplasms of the pancreas: Differential diagnosis with neuroendocrine tumours. Eur Radiol. 2016 May;26(5):1348-58. doi: 10.1007/s00330-015-3961-3. Epub 2015 Sep 2. PMID: 26328927 149. Springer S, Wang Y, Molin MD, Masica DL, Jiao Y, Kinde I, Blackford A, Raman SP, Wolfgang CL, Tomita T, Niknafs N, Douville C, Ptak J, Dobbyn L, Allen PJ, Klimstra DS, Schattner MA, Schmidt MC, Yip-Schneider M, Cummings OW, Brand RE, Zeh HJ, Singhi AD,

Scarpa A, Salvia R, Malleo G, Zamboni G, Falconi M, Jang JY, Kim SW, Kwon W, Hong SM, Song KB, Kim SC, Swan N, Murphy J, Geoghegan J, Brugge W, Fernandez-Del Castillo C, Mino-Kenudson M, Schulick R, Edil BH, Adsay V, Paulino J, van Hooft J, Yachida S, Nara S, Hiraoka N, Yamao K, Hijioka S, van der Merwe S, Goggins M, Canto MI, Ahuja N, Hirose K, Makary M, Weiss MJ, Cameron J, Pittman M, Eshleman JR, Diaz LA Jr, Papadopoulos N, Kinzler KW, Karchin R, Hruban RH, Vogelstein B, Lennon AM. A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts. Gastroenterology. 2015 Nov;149(6):1501-10. doi: 10.1053/j.gastro.2015.07.041. Epub 2015 Aug 4. PMID: 26253305

147. Kim DW, Kim HJ, Kim KW, Byun JH, Kim SY, Song KB, Ramaiya NH, Tirumani SH, Hong

SM. Prognostic value of CT findings to predict survival outcomes in patients with pancreatic neuroendocrine neoplasms: a single institutional study of 161 patients. Eur Radiol. 2016 May;26(5):1320-9. doi: 10.1007/s00330-015-3943-5. Epub 2015 Aug 8. PMID: 26253259

147. Kim DJ, Park YS, Kang MG, You YM, Jung Y, Koo H, Kim JA, Kim MJ, Hong SM, Lee KB, Jang JJ, Park KC, Yeom YI. Pyruvate kinase isoenzyme M2 is a therapeutic target of gemcitabine-resistant pancreatic cancer cells. Exp Cell Res. 2015 Aug 1;336(1):119-29. doi: 10.1016/j.yexcr.2015.05.017. Epub 2015 Jun 22. PMID: 26112218

146. Schlitter AM, Jang KT, Klöppel G, Saka B, Hong SM, Choi H, Offerhaus GJ, Hruban RH, Zen Y, Konukiewitz B, Regel I, Allgäuer M, Balci S, Basturk O, Reid MD, Esposito I, Adsay V. Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases. Mod Pathol. 2015 Sep;28(9):1249-64. doi: 10.1038/modpathol.2015.61. Epub 2015 Jun 26. PMID: 26111977

145. Yoon YS, Kim J, Hong SM, Lee JL, Kim CW, Park IJ, Lim SB, Yu CS, Kim JC. Clinical implications of mucinous components correlated with microsatellite instability in patients with colorectal cancer. Colorectal Dis. 2015 Aug;17(8):O161-7. doi: 10.1111/codi.13027. PMID: 26095997

144. An S, Jang J, Min K, Kim MS, Park H, Park YS, Kim J, Lee JH, Song HJ, Kim KJ, Yu E,

Hong SM2. Granular cell tumor of the gastrointestinal tract: histologic and immunohistochemical

Hong- 23

analysis of 98 cases. Hum Pathol. 2015 Jun;46(6):813-9. doi: 10.1016/j.humpath.2015.02.005. Epub 2015 Feb 26. PMID: 25882927

143. Seo N, Byun JH, Kim JH, Kim HJ, Lee SS, Song KB, Kim SC, Han DJ, Hong SM, Lee MG. Validation of the 2012 International Consensus Guidelines Using Computed Tomography and Magnetic Resonance Imaging: Branch Duct and Main Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg. 2016 Mar;263(3):557-64. doi: 10.1097/SLA.0000000000001217. PMID: 25822687

142. Son EM, Kim JY, An S, Song KB, Kim SC, Yu E, Hong SM2. Clinical and Prognostic Significances of Cytokeratin 19 and KIT Expression in Surgically Resectable Pancreatic Neuroendocrine Tumors. J Pathol Transl Med. 2015 Jan;49(1):30-6. doi: 10.4132/jptm.2014.10.23. Epub 2015 Jan 15. PMID: 25812655

141. Kim TH, Song MJ, Lee JH, Hong SM. Bleeding from a gastric subepithelial tumor associated with eosinophilia. Gastrointest Endosc. 2015 May;81(5):1284-5. doi: 10.1016/j.gie.2014.11.020. Epub 2015 Mar 6. No abstract available. PMID: 25746982 140. Kim JY, Kim KS, Kim KJ, Park IJ, Lee JL, Myung SJ, Park Y, Park YS, Yu CS, Kim JC, Yu

E, Jang HJ, Hong SM2. Non-L-cell Immunophenotype and Large Tumor Size in Rectal Neuroendocrine Tumors Are Associated With Aggressive Clinical Behavior and Worse Prognosis. Am J Surg Pathol. 2015 May;39(5):632-43. doi: 10.1097/PAS.0000000000000400. PMID: 25724002

139. Eom DW, Hong SM, Kim G, Bae YK, Jang KT, Yu E. Prognostic Significance of CD44v6, CD133, CD166, and ALDH1 Expression in Small Intestinal Adenocarcinoma. Appl Immunohistochem Mol Morphol. 2015 Nov-Dec;23(10):682-8. doi: 10.1097/PAI.0000000000000140. PMID: 25710579

138. Min KW, Kim DY, Lee SO, Hong SM2. Education and imaging. Gastrointestinal: a case of histologically confirmed scrub typhus gastritis.J Gastroenterol Hepatol. 2015 Mar;30(3):435. doi: 10.1111/jgh.12824. No abstract available. PMID: 25707787 137. Kim JY, Kim MS, Kim KS, Song KB, Lee SH, Hwang DW, Kim KP, Kim HJ, Yu E, Kim

SC, Jang HJ, Hong SM2. Clinicopathologic and prognostic significance of multiple hormone expression in pancreatic neuroendocrine tumors. Am J Surg Pathol. 2015 May;39(5):592-601. doi: 10.1097/PAS.0000000000000383. PMID: 25602797 136. Type 1 autoimmune pancreatitis with histologically proven granulocytic epithelial lesions.

Song JE, Han J, Kim HG, Kim MH, Hong SM. Pancreatology. 2015 May-Jun;15(3):305-7. doi: 10.1016/j.pan.2014.11.007. Epub 2014 Dec 10. PMID: 25524485

135. Hwang J, Kim DY, Kim SC, Namgoong JM, Hong SM. Solid-pseudopapillary neoplasm of the pancreas in children: Can we predict malignancy? J Pediatr Surg. 2014 Dec;49(12):1730-3. doi: 10.1016/j.jpedsurg.2014.09.011. Epub 2014 Nov 13. PMID: 25487471

134. Kim DW, Kim HJ, Kim KW, Byun JH, Song KB, Kim JH, Hong SM. Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour. Eur Radiol. 2014 Dec 3.

Hong- 24

[Epub ahead of print] PMID: 25465713

133. Bae JS, Song JS, Hong SM, Moon WS. An unusual presentation of an inflammatory fibroid polyp of the ileum: A case report. Oncol Lett. 2015 Jan;9(1):327-329. Epub 2014 Nov 5. PMID: 25435986

132. Handra-Luca A, Hong SM. Heterogeneity of Luschka Ducts of the Gallbladder. Appl Immunohistochem Mol Morphol. 2014 Oct 29. [Epub ahead of print] No abstract available. PMID: 25356947

131. Park SJ, Kim SM, Hong YS, Lee JL, Kim JE, Kim KP, Hong SM, Jin DH, Kim CW, Yoon YS, Park IJ, Lim SB, Yu CS, Kim JC, Kim TW. TFAP2E Methylation Status and Prognosis of Patients with Radically Resected Colorectal Cancer. Oncology. 2014 Oct 23;88(2):122-132. [Epub ahead of print] PMID: 25341849 130. Park H, An S, Eo SH, Song KB, Park JH, Kim KP, Lee SS, Cho H, Seo DW, Kim SC, Yu E,

Hong SM2. Survival effect of tumor size and extrapancreatic extension in surgically resected pancreatic cancer: proposal for improved T classification. Hum Pathol. 2014 Nov;45(11):2341-6. doi: 10.1016/j.humpath.2014.06.030. Epub 2014 Aug 23. PMID: 25248573

129. Song KB, Kim SC, Kim JH, Hong SM, Park KM, Hwang DW, Lee JH, Lee YJ. Prognostic factors in 151 patients with surgically resected non-functioning pancreatic neuroendocrine tumours. ANZ J Surg. 2016 Jul;86(7-8):563-7. doi: 10.1111/ans.12738. Epub 2014 Jul 9. PMID: 25040037

128. Hong N, Kim HJ, Byun JH, Kim SY, Kim KW, Kim JH, Hong SM. Neuroendocrine neoplasms of the extrahepatic bile duct: radiologic and clinical characteristics. Abdom Imaging. 2015 Jan;40(1):181-91. doi: 10.1007/s00261-014-0191-0. PMID: 25008023

127. Zhong Y, Naito Y, Cope L, Naranjo-Suarez S, Saunders T, Hong SM, Goggins M, Herman JM, Wolfgang CL, Iacobuzio-Donahue CA. Functional p38 MAPK Identified by Biomarker Profiling of Pancreatic Cancer Restrains Growth through JNK Inhibition and Correlates with Improved Survival. Clin Cancer Res. 2014 Dec 1;20(23):6200-11. doi: 10.1158/1078-0432.CCR-13-2823. Epub 2014 Jun 24. PMID: 24963048

126. Kim DW, Kim JH, Park SH, Lee JS, Hong SM, Kim M, Ha HK. Heterotopic pancreas of the jejunum: associations between CT and pathology features.Abdom Imaging. 2015 Jan;40(1):38-45. doi: 10.1007/s00261-014-0177-y. PMID: 24934475

125. Chung JY, Braunschweig T, Hong SM, Kwon DS, Eo SH, Cho H, Hewitt SM. Assessment of vascular endothelial growth factor in formalin fixed, paraffin embedded colon cancer specimens by means of a well-based reverse phase protein array. Proteome Sci. 2014 May 13;12:27. doi: 10.1186/1477-5956-12-27. eCollection 2014. PMID: 24883046

124. Paik WH, Park Y, Park DH, Hong SM, Lee BU, Choi JH, Lee SS, Seo DW, Lee SK, Kim MH. Prospective Evaluation of New 22 Gauge Endoscopic Ultrasound Core Needle Using Capillary Sampling With Stylet Slow-Pull Technique for Intra-Abdominal Solid Masses. J Clin Gastroenterol. 2015 Mar;49(3):199-205. doi: 10.1097/MCG.0000000000000084. PMID: 24921417

123. Vincent A, Hong SM, Hu C, Omura N, Young A, Kim H, Yu J, Knight S, Ayars M, Griffith M, Van Seuningen I, Maitra A, Goggins M. Epigenetic silencing of EYA2 in pancreatic

Hong- 25

adenocarcinomas promotes tumor growth. Oncotarget. 2014 May 15;5(9):2575-87. PMID: 24810906

122. Eom DW, Hong SM, Kim J, Kim G, Bae YK, Jang KT, Yu E. Notch3 signaling is associated with MUC5AC expression and favorable prognosis in patients with small intestinal adenocarcinomas. Pathol Res Pract. 2014 Aug;210(8):501-7. doi: 10.1016/j.prp.2014.04.003. Epub 2014 Apr 18. PMID: 24810798

121. Ahn SM, Jang SJ, Shim JH, Kim D, Hong SM, Sung CO, Baek D, Haq F, Ansari AA, Lee SY, Chun SM, Choi S, Choi HJ, Kim J, Kim S, Hwang S, Lee YJ, Lee JE, Jung WR, Jang HY, Yang E, Sung WK, Lee NP, Mao M, Lee C, Zucman-Rossi J, Yu E, Lee HC, Kong G. A genomic portrait of resectable hepatocellular carcinomas: Implications of RB1 and FGF19 aberrations for patient stratification.Hepatology. 2014 Dec;60(6):1972-82. doi: 10.1002/hep.27198. Epub 2014 Sep 22. PMID: 24798001

120. Kim JY, Song JS, Park H, Byun JH, Song KB, Kim KP, Kim SC, Hong SM2. Primary Mesenchymal Tumors of the Pancreas: Single-Center Experience Over 16 Years. Pancreas. 2014 Aug;43(6):959-68. doi: 10.1097/MPA.0000000000000130. PMID: 24743377

119. Park JS, Lim KM, Park SG, Jung SY, Choi HJ, Lee do H, Kim WJ, Hong SM, Yu ES, Son WC. Pancreatic cancer induced by in vivo electroporation-enhanced sleeping beauty transposon gene delivery system in mouse. Pancreas. 2014 May;43(4):614-8. doi: 10.1097/MPA.0000000000000102. PMID: 24713671

118. Shin SH, Kim SC, Hong SM, Song KB, Lee JH, Park KM, Lee YJ. Can statistically determined prognostic factors predict the long-term survival of patients with pancreatic ductal adenocarcinoma following surgical resection?: clinicopathological analysis of 82 long-term survivors. Pancreas. 2014 May;43(4):571-7. doi: 10.1097/MPA.0000000000000063. PMID: 24681875

117. Jun SY, Eom DW, Park H, Bae YK, Jang KT, Yu E, Hong SM2. Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma. Mod Pathol. 2014 Oct;27(10):1364-74. doi: 10.1038/modpathol.2014.36. Epub 2014 Mar 7. PMID: 24603585

116. Kim JY, Choi JH, Kim JH, Kim CL, Bae SH, Choi YK, Ha Y, Song MJ, Choi JH, Hong SM, Kim MH. Clinical usefulness of bile cytology obtained from biliary drainage tube for diagnosing cholangiocarcinoma. Korean J Gastroenterol. 2014 Feb 25;63(2):107-13. Korean.

115. Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, Antonarakis ES, Azad NS, Bardelli A, Brem H, Cameron JL, Lee CC,

Fecher LA, Gallia GL, Gibbs P, Le D, Giuntoli RL, Goggins M, Hogarty MD, Holdhoff M, Hong

SM, Jiao Y, Juhl HH, Kim JJ, Siravegna G, Laheru DA, Lauricella C, Lim M, Lipson EJ, Marie SK, Netto GJ, Oliner KS, Olivi A, Olsson L, Riggins GJ, Sartore-Bianchi A, Schmidt K, Shih lM, Oba-Shinjo SM, Siena S, Theodorescu D, Tie J, Harkins TT, Veronese S, Wang TL, Weingart JD, Wolfgang CL, Wood LD, Xing D, Hruban RH, Wu J, Allen PJ, Schmidt CM, Choti MA, Velculescu VE, Kinzler KW, Vogelstein B, Papadopoulos N, Diaz LA Jr. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014 Feb 19;6(224):224ra24. doi: 10.1126/scitranslmed.3007094.

114. Lee JL, Yu CS, Kim M, Hong SM, Lim SB, Kim JC. Prognostic impact of diagnosing colorectal neuroendocrine carcinoma using the World Health Organization 2010 classification.

Hong- 26

Surgery. 2014 Apr;155(4):650-8. doi: 10.1016/j.surg.2013.11.012. Epub 2013 Nov 22.

113. Kim HJ, Yu ES, Byun JH, Hong SM, Kim KW, Lee JS, Kim SY. CT Differentiation of Mucin-Producing Cystic Neoplasms of the Liver From Solitary Bile Duct Cysts.AJR Am J Roentgenol. 2014 Jan;202(1):83-91. doi: 10.2214/AJR.12.9170.

112. Eo SH, Hong SM, Cho H. K-adaptive partitioning for survival data with an application to SEER: The kaps add-on package for R. J Stat Software. Submitted, 2012.

111. Chopra P, Kang J, Hong SM. Comparative meta-analysis between human and mouse cancer microarray data reveals critical pathways. 2013 Int J Data Min Bioinform. 2013;8(3):349-65.

110. Kim SA, Kim MS, Kim MS, Kim SC, Choi J, Yu E, Hong SM2. Pleomorphic solid pseudopapillary neoplasm of the pancreas: degenerative change rather than high-grade malignant potential. Hum Pathol. 2014 Jan;45(1):166-74. doi: 10.1016/j.humpath.2013.08.016.

109. Kim GU, Kim KJ, Hong SM, Yu ES, Yang DH, Jung KW, Ye BD, Byeon JS, Myung SJ,

Yang SK, Kim JH. Clinical outcomes of rectal neuroendocrine tumors ≤  10 mm following endoscopic resection. Endoscopy. 2013 Dec;45(12):1018-23. doi: 10.1055/s-0033-1344860. Epub 2013 Nov 28.

108. Kang HJ, Eo SH, Kim SC, Park KM, Lee YJ, Lee SK, Yu E, Cho H, Hong SM2. Increased number of metastatic lymph nodes in adenocarcinoma of the ampulla of Vater as a prognostic factor: A proposal of new nodal classification. Surgery. 2014 Jan;155(1):74-84. doi: 10.1016/j.surg.2013.08.004. Epub 2013 Nov 12.

107. Jang S, Chun SM, Hong SM, Sung CO, Park H, Kang HJ, Kim KP, Lee YJ, Yu E. High throughput molecular profiling reveals differential mutation patterns in intrahepatic cholangiocarcinomas arising in chronic advanced liver diseases. Mod Pathol. 2014 May;27(5):731-9. doi: 10.1038/modpathol.2013.194. Epub 2013 Nov 1. PMID: 24186137

106. Roh J, Knight S, Chung JY, Eo SH, Goggins M, Kim J, Cho H, Yu E, Hong SM2. S100A4 expression is a prognostic indicator in small intestine adenocarcinoma. J Clin Pathol. 2014 Mar;67(3):216-21. doi: 10.1136/jclinpath-2013-201883. Epub 2013 Sep 23. PMID: 24062356

105. Kim A, Bae YK, Gu MJ, Kim JY, Jang KY, Bae HI, Lee HJ, Hong SM. Epithelial-mesenchymal transition phenotype is associated with patient survival in small intestinal adenocarcinoma.Pathology. 2013 Oct;45(6):567-73. doi: 10.1097/PAT.0b013e3283650bab.

104. Park SH, Yang SK, Hong SM, Park SK, Kim JW, Lee HJ, Yang DH, Jung KW, Kim KJ, Ye BD, Byeon JS, Myung SJ, Kim JH. Severe Disease Activity and Cytomegalovirus Colitis Are Predictive of a Nonresponse to Infliximab in Patients with Ulcerative Colitis. Dig Dis Sci. 2013 Dec;58(12):3592-9. doi: 10.1007/s10620-013-2828-1. Epub 2013 Aug 25.

103. Kim SY, Park SH, Hong N, Kim JH, Hong SM. Primary solid pancreatic tumors: recent imaging findings updates with pathology correlation. Abdom Imaging. 2013 Oct;38(5):1091-105. doi: 10.1007/s00261-013-0004-x.

102. Xiao H, Yoon YS, Hong SM, Roh SA, Cho DH, Yu CS, Kim JC. Poorly differentiated colorectal cancers: correlation of microsatellite instability with clinicopathologic features and

Hong- 27

survival. Am J Clin Pathol. 2013 Sep;140(3):341-7.

101. Gu MJ, Hong SM, Jung SJ; Korean Small Intestinal Cancer Study Group. HER2 protein expression and HER2 gene amplification are infrequent in small intestinal carcinomas. Virchows Arch. 2013 Jun;462(6):603-7. doi: 10.1007/s00428-013-1425-1. Epub 2013 May 24.

100., Kang HS, Hong SM, Tsao MS, Kim S, Lee DK. Alkaline Phosphatase ALPPL-2 Is a Novel Pancreatic Carcinoma-Associated Protein. Cancer Res. 2013 Mar 15;73(6):1934-45.

99. Min KW, Koh YW, Ryu YJ, Hong SM, Kim KR, Sung CO. Primary clear cell adenocarcinoma arising from rectal endometriosis. Dig Endosc. 2013 Mar;25(2):209-10. doi: 10.1111/den.12008. Epub 2012 Dec 17.

98. Shin SH, Kim SC, Hong SM, Kim YH, Song KB, Park KM, Lee YJ. Genetic Alterations of K-ras, p53, c-erbB-2, and DPC4 in Pancreatic Ductal Adenocarcinoma and Their Correlation With Patient Survival. Pancreas. 2013 Mar;42(2):216-22.

97. Lee HJ, Lee OJ, Jang KT, Bae YK, Chung JY, Ph.D, Eom DW, Kim JM, Yu E, Hong SM2. Loss of the E-cadherin and aberrant β-catenin proteins expression correlates with a poor prognosis for small intestinal adenocarcinomas. Am J Clin Pathol. 2013 Feb;139(2):167-76.

96. Lee SJ, Yu E, Bae YK, Jang KT, Kim JM, Bae HI, Hong SM, Yoon GS; The Korean Small Intestinal Cancer Study Group. DPC4 Expression in the Small Intestinal Adenocarcinomas. Korean J Pathol. 2012 Oct;46(5):415-422. Epub 2012 Oct 25.

95. Lim SB, Hong SM, Yu CS, Hong YS, Kim TW, Park JH, Kim JH, Kim JC. Prevalence and Clinical Significance of Acellular Mucin in Locally Advanced Rectal Cancer Patients Showing Pathologic Complete Response to Preoperative Chemoradiotherapy. Am J Surg Pathol. 2013 Jan;37(1):47-52.

94. Lee HJ, Chung JY, Hewitt SM, Yu E, Hong SM2. HER3 Overexpression is a Prognostic Indicator of Extrahepatic Cholangiocarcinoma. Virchows Arch. 2012 Nov;461(5):521-30. doi: 10.1007/s00428-012-1321-0. Epub 2012 Oct 2.

93. Kim G, Chung JY, Jun SY, Eom DW, Bae YK, Jang KT, Kim J, Yu E, Hong SM2. Loss of S100A14 expression is associated with the progression of adenocarcinomas of the small intestine. Pathobiology. 2013;80(2):95-101. doi: 10.1159/000342394. Epub 2012 Oct 3.

92. Yu J, Walter K, Omura N, Hong SM, Young A, Li A, Vincent A, Goggins M. Unlike pancreatic cancer cells pancreatic cancer associated fibroblasts display minimal gene induction after 5-aza-2'-deoxycytidine. PLoS One. 2012;7(9):e43456. Epub 2012 Sep 11.

91. Jang TY, Yu CS, Yoon YS, Lim SB, Hong SM, Kim TW, Kim JH, Kim JC. Oncologic Outcome After Preoperative Chemoradiotherapy in Patients With Pathologic T0 (ypT0) Rectal Cancer. Dis Colon Rectum. 2012 Oct;55(10):1024-31.

90. Chun YS, Bisht S, Chenna V, Pramanik D, Yoshida T, Hong SM, de Wilde RF, Zhang Z, Huso D, Zhao M, Rudek M, Stearns V, Maitra A, Sukumar S. Intraductal Administration of a Polymeric Nanoparticle Formulation of Curcumin (NanoCurc) Significantly Attenuates Incidence

Hong- 28

of Mammary Tumors in a Rodent Chemical Carcinogenesis Model Implications for breast cancer chemoprevention in at-risk populations. Carcinogenesis. 2012 Nov;33(11):2242-9. doi: 10.1093/carcin/bgs248. Epub 2012 Jul 25.

89. Hong SM, Vincent A, Kanda M, Leclerc J, Omura N, Borges M, Klein AP, Canto M, Hruban RH, Goggins M. Genome-wide somatic copy number alterations in low-Grade PanINs and IPMNs from individuals with a family history of Pancreatic Cancer. Clin Cancer Res. 2012 18(16):4303-12. Epub 2012 Jun 21.

88. Jung G, Park KM, Lee SS, Yu E, Hong SM, Kim J. Long-term Clinical Outcome of the Surgically Resected Intraductal Papillary Neoplasm of the Bile Duct. J Hepatol. 2012 Oct;57(4):787-93. Epub 2012 May 23.

87. Gu M, Bae YK, Kim A, Hong SM, Yu E, Kim J, Jang KT, Chang HK, Jung ES, Bae HI, Yoon GS, Kim JM, Kim JY, Kim GI, Oh YH, Jang KY, Jun SY, Eom DW, Kwon KW, Kang GH, Park JB, Hong S, Jung SJ, Lee JS; The Korean Small Intestinal Cancer Study Group. Expression of hMLH1, hMSH2 and hMSH6 in Small Intestinal Carcinomas Hepatogastroenterology. 2012 Oct;59(119):2228-32. PMID: 22456432

86. Kanda M, Matthaei H, Wu J, Hong SM, Yu J, Borges M, Hruban RH, Maitra A, Kinzler K, Vogelstein B, Goggins M. Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia. Gastroenterology. 2012 142(4):730-733.e9. Epub 2012 Jan 5.

85. Hong SM, Omura N, Vincent A, Li A, Knight S, Yu J, Hruban RH, Goggins M. Genome-wide CpG Island Profiling of Intraductal Papillary Mucinous Neoplasms of the Pancreas. Clin Cancer Res. 2012 18(3):700-12. Epub 2011 Dec 15.

84. Matthaei H, Norris AL, Tsiatis AC, Olino K, Hong SM, Dal Molin M, Goggins MG, Canto M, Horton KM, Jackson KD, Capelli P, Zamboni G, Bortesi L, Furukawa T, Egawa S, Ishida M, Ottomo S, Unno M, Motoi F, Wolfgang CL, Edil BH, Cameron JL, Eshleman JR, Schulick RD, Maitra A, Hruban RH.Clinicopathological Characteristics and Molecular Analyses of Multifocal Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg. 2012 Feb;255(2):326-33.

83. Yu J, Li A, Hong SM, Hruban RH, Goggins M. MicroRNA Alterations of Pancreatic Intraepithelial Neoplasms (PanINs). Clin Cancer Res. 2012 Feb 15;18(4):981-92. Epub 2011 Nov 23.

82. Hong SM, Goggins M, Wolfgang CL, Schulick RD, Edil BH, Cameron JL, Handra-Luca A, Herman JM, Hruban RH. Vascular Invasion in Infiltrating Ductal Adenocarcinoma of the Pancreas Can Mimic Pancreatic Intraepithelial Neoplasia: A Histopathologic Study of 209 Cases. Am J Surg Pathol, 2012 Feb;36(2):235-41.

81. Dal Molin M, Hong SM, Hebbar S, Sharma R, Scrimieri F, de Wilde R, Mayo SC, Goggins M, Wolfgang CL, Schulick RD, Lin MT, Eshleman JR, Hruban RH, Maitra A, Matthaei H. Loss of expression of the SWI/SNF chromatin modeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas. Human Pathol 2012

Hong- 29

Apr;43(4):585-91. doi: 10.1016/j.humpath.2011.06.009. Epub 2011 Sep 21. PMID: 21940037

80. Chenna V, Hu C, Pramanik D, Aftab BT, Karikari C, Campbell NR, Hong SM, Zhao M, Rudek MA, Khan SR, Rudin CM, Maitra A. A Polymeric Nanoparticle Encapsulated Small Molecule Inhibitor of Hedgehog Signaling (NanoHHI) Bypasses Secondary Mutational Resistance to Smoothened Antagonists. Mol Cancer Ther. 2012 Jan; 11(1): 165-73. Epub 2011 Oct 25.

79. Gupta S, Pramanik D, Mukherjee R, Campbell NR, Elumalai S, de Wilde RF, Hong SM, Goggins M, De Jesus-Acosta A, Laheru D, Maitra A. Molecular Determinants of Retinoic Acid Sensitivity in Pancreatic Cancer. Clin Cancer Res. 2012 Jan,1:18(10):280-9 Epub 2011 Oct 25.

78. Heaphy CM, Subhawong AP, Hong SM, Goggins MG, Montgomery EA, Gabrielson E, Netto GJ, Epstein JI, Lotan T, Westra WH, Shih IM, Iacobuzio-Donahue CA, Maitra A, Li QK, Eberhart CG, Taube JM, Rakheja D, Kurman RJ, Wu TC, Roden RB, Argani P, De Marzo AM, Terracciano L, Torbenson M, Meeker AK. Prevalence of the alternative lengthening of telomeres (ALT) telomere maintenance mechanism in human cancer subtypes. Am J Pathol, 179(4): 1608-15, 2011.

77. Takikita M, Xie R, Chung JY, Cho H, Ylaya K, Hong SM, Moskaluk CA, Hewitt SM. Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma. J Transl Med, 9(1): 126, 2011.

76. Ryu JR, Matthaei H, dal Molin M, Hong SM, Canto MI, Schulick RD, Wolfgang C, Goggins MG, Hruban RH, Cope L, Maitra A. Elevated MicroRNA miR-21 Levels in Pancreatic Cyst Fluid are Predictive of Mucinous Precursor Lesions of Ductal Adenocarcinoma. Pancreatology, 11 (3):343-350, 2011.

75. de Jong MC1, Hong SM1, Augustine MM, Goggins MG, Wolfgang CL, Hirose K, Schulick RD, Choti MA, Anders RA, Pawlik TM. Hilar cholangiocarcinoma: Tumor depth as a predictor of outcome. Arch Surg, 146(6):697-703, 2011.

74. Vincent A, Omura N, Hong SM, Jaffe A, Eshleman J, Goggins M. Genome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma. Clin Cancer Res, 17(13):4341-54, 2011.

73. Hong SM, Park JY, Hruban RH, Goggings M. Molecular Signatures of Pancreatic Cancer. Arch Pathol Lab Med, 135(6):716-27, 2011.

72. Hong SM, Li A, Olino K, Wolfgang CL, Herman JM, Schulick RD, Iacobuzio-Donahue C, Hruban RH, Goggins M. Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomas. Mod Pathol, 24(9): 1237-47, 2011.

71. Matthaei H, Hong SM1, Mayo SC, dal Molin M, Olino K, Venkat R, Goggins M, Herman JM, Edil BH, Wolfgang CL, Cameron JL, Schulick RD, Maitra A, Hruban RH. Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer. Ann Sur Oncol, 18; 12: 3493-9, 2011.

70. Handra-Luca A, Hong SM, Walter K, Wolfgang CM, Hruban RH, Goggins M. Tumoral vimentin expression and outcome of pancreatic ductal adenocarcinomas. British J Cancer,

Hong- 30

104;8: 1296-1302, 2011.

69. Park, JY, Hong SM, Klimstra DS, Goggins MG, Maitra A, Hruban RH. Pdx1 Expression in Pancreatic Precursor Lesions and Neoplasms. Appl Immunohistochem Mol Morphol. 19:5: 444-9.

68. Eom DW, Kang GH, Han SH, Cheon GJ, Han KH, Oh HS, Kim JH, Jang HJ, Hong SM. Gastric Micropapillary Carcinoma: A Distinct Subtype With a Significantly Worse Prognosis in TNM Stages I and II. Am J Surg Pathol, 35;1:84-91, 2011.

67. Hong SM, Heaphy CM, Shi C, Eo SH, Cho H, Meeker AK, Eshleman JR, Hruban RH, Goggins M. Telomeres are shortened in acinar-to-ductal metaplasia lesions associated with pancreatic intraepithelial neoplasia but not in isolated acinar-to-ductal metaplasias. Mod Pathol, 24;2: 256-266, 2011.

66. Alvarez H, Montgomery EA, Karikari C, Canto M, Dunbar KB, Wang JS, Fledmann G, Hong

SM, Haffner MC, Meeker AK, Holland SJ, Yu J, Heckrodt TJ, Zhang J, Ding P, Goff D, Singh R, Roa JC, Marimuthu A, Riggins GJ, Eshleman JR, Pandey A, Maitra A. The Axl receptor tyrosine kinase is an adverse prognostic factors and a therapeutic target in esophageal adenocarcinoma. Cancer Biol Ther,10;10: 1009-18, 2010.

65. Vilgelm AE, Hong SM, Washington MK, Wei J, Chen H, El-Rifai W, Zaika A. Characterization of DeltaNp73 expression and regulation in gastric and esophageal tumors. Oncogene, 29; 43: 5861-8, 2010.

64. Bisht S, Mizuma M, Feldmann G,Ottenhof N, Hong SM, Pramanik D, Chenna V, Karikari C, Sharma R, Goggins MG, Rudek M, Ravi R, Maitra A, Maitra A. Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol Cancer Ther, 9;8: 2255-64, 2010.

63. Li A, Omura N, Hong SM, Vincent A, Walter K, Griffith M, Borges M, Goggins M. Pancreatic Cancers Epigenetically Silence SIP1 and Hypomethylate and Overexpress miR-200a/200b in Association with Elevated Circulating miR-200a and miR-200b Levels. Cancer Res, 70; 13: 5226-37, 2010.

62. Omura N, Griffith M, Vincent A, Li A, Hong SM, Walter K, Borges M, Goggins M. Cyclooxygenase-deficient pancreatic cancer cells utilize exogenous sources of prostaglandins. Mol Cancer Res, 8; 6: 821-32, 2010.

61. Feldmann G, Mishra A, Hong SM, Bisht S, Strock CJ, Ball DW, Goggins MG, Maitra A, Nelkin BD. Inhibiting the Cyclin-Dependent Kinase CDK5 Blocks Pancreatic Cancer Formation and Progression through the Suppression of Ras-Ral Signaling. Cancer Res, 70; 11: 4460-9, 2010. 60. Chang HK, Yu E, Kim J, Bae YK, Jang KT, Jung ES, Yoon GS, Kim JM, Oh YH, Bae HI, Kim GI, Jung SJ, Gu M, Kim JY, Jang KY, Jun SY, Eom DW, Kwon KW, Kang GH, Park JB, Hong

SW, Lee JS, Park JY, Hong SM 2. Adenocarcinoma of the small intestine: A multi-institutional study of 197 surgically resected cases. Hum Pathol, 41; 8: 1087-91, 2010.

59. Ryu JK, Hong SM2, Karikari CA, Hruban RH, Goggins MG, Maitra A. Aberrant MicroRNA miR-155 Expression is an Early Event in the Multistep Progression of Pancreatic

Hong- 31

Adenocarcinoma. Pancreatology, 10; 1: 66-73, 2010.

58. Kamiyama H, Kamiyama M, Hong SM, Karikari C, Lin MT, Borges M, Griffith M, Young A, Norris-Kirby A, Lubek C, Mizuma M, Feldmann G, Shi C, Liang H, Goggins M, Maitra A, Hruban RH, Eshleman JR. In vivo and in vitro Propagation of Intraductal Papillary Mucinous Neoplasms. Lab Invest, 90; 5: 665-73, 2010.

57. Li A, Omura N, Hong SM, Goggins M. Pancreatic cancer DNMT1 expression and sensitivity to DNMT1 inhibitors. Cancer Biol Ther, 9; 4: 321-329, 2010.

56. Walter K, Omura N, Hong SM, Griffith M, Vincent A, Borges M, Goggins M. Overexpression of Smoothened activates Sonic Hedgehog signaling pathway in pancreatic cancer-associated fibroblasts. Clin Cancer Res, 16; 6: 1781-9, 2010.

55. Rasheed ZA, Yang J, Wang Q, Freed I, Murter C, Hong SM, Koorstra JB, Rajeshkumar NV, Goggins M, Iacobuzio-Donahue C, Laheru D, Jimeno A, Hidalgo M, Maitra A, Matsui WH. Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic Adenocarcinoma. J Nat Cancer Institutions, 102; 5: 340-51, 2010.

54. Walter K, Hong SM, Nyhan S, Canto M, Fedarko N, Klein A, Griffith M, Omura N, Medghalchi S, Kuhajda F, Goggins M. Serum Fatty Acid Synthase as a marker of pancreatic neoplasia. Cancer Epidemiol Biomarkers Prev, 18; 9: 2380-2385, 2009.

53. Koorstra JB, Hong SM1,2, Ryu JK, Offerhaus GJ, Shi C, Meeker AK, Shih IM, Schulick R, Goggins MG, Hruban RH, Maitra A. Widespread activation of the DNA damage response in human pancreatic intraepithelial neoplasia. Mod Pathol, 22; 11: 1439-45, 2009.

52. Hong SM1, Pawlik TM, Cho H, Aggarwal B, Goggins M, Hruban RH, Anders RA. Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma. Surgery, 146; 2: 250-257, 2009.

51. Haack H, Johnson LA, Fry CJ, Crosby K, Polakiewicz RD, Stelow EB, Hong SM, Schwartz BE, Cameron MJ, Rubin MA, Chang MC, Aster JC, French CA. Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal Antibody. Am J Surg Pathol, 33; 984-91, 2009.

50. Klein AP, Borges M, Griffith M, Brune K, Hong SM, Omura N, Hruban RH, Goggins M. Absence of deleterious palladin mutations in patients with familial pancreatic cancer. Cancer Epidemiol Biomarkers Prev, 18;4: 1328-30, 2009.

49. Shi C, Hong SM 1, Lim P, Kamiyama H, Khan M, Anders RA, Goggins M, Hruban RH, Eshleman JR. KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: Implications for the human pancreatic cancer cell of origin. Mol Cancer Res, 7; 2: 230-236, 2009. 48. Habbe N, Koorstra JB, Mendell JR, Offerhaus GJ, Ryu JK, Feldmann G, Mullendore ME,

Goggins G, Hong SM2, Maitra A. MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther, 8; 4: 340-346, 2009.

47. Chung JY, Hong SM 1, Choi BY, Cho HJ, Yu Y, Hewitt SM. The expresison of phospho-AKT, phospho-mTOR, and PTEN in extrahepatic cholangioicarcinoma. Clin Cancer Res, 15; 2: 660-667, 2009.

Hong- 32

46. Cho H, Yu A, Kim S, Kang J, Hong SM. Robust likelihood-based survival modeling with microarray data. J Stat Soft, 29; 1: 1-16 , 2009.

45. Brune K, Hong SM, Li A, Yachida S, Abe T, Griffith M, Yang D, Omura N, Eshleman JR, Canto M, Schulick R, Klein AP, Hruban RH, Iacobuzio-Donohue C, Goggins M. Genetic and epigenetic alterations of familial pancreatic cancers.Cancer Epidemiol Biomarkers Prev, 17; 12:3536-3542, 2008.

44. Alvarez H, Koorstra JB, Hong SM, Boonstra JJ, Dinjens WN, Wu TT, Montgomery E, Eshleman JR, Maitra A. Establishment and characterization of a bona fide barrett esophagus-associated adenocarcinoma cell line. Cancer Biol Ther. 7; 11: 1753-1755, 2008.

43. Hong SM, Kelly D, Griffith M, Omura N, Li A, Li CP, Hruban RH, Goggins M. Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas . Mod Pathol, 21; 12: 1499-1507, 2008.

42. Jang KT, Hong SM1, Lee KT, Lee JG, Choi SH, Heo JS, Choi DW, Choi D, Lim JH. Intraductal papillary neoplasm of the bile duct associated with Clonorchis sinensis infection. Virchows Arch, 453; 6: 589-98, 2008. 41. Jones S, Zhang X, Parsons DW, Lin JCH, Leary RJ, Angenendt P, Mankoo P, Carter H,

Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio-Donahue C, Eshleman JR, Kern SE, Hruban RH, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 321;5897: 1801-6: 2008.

40. Omura N, Li CP, Li A, Hong SM, Walter K, Jimeno A, Hidalgo M, Goggins M. Genome-wede profiling of methylated promoters in pancreatic adenocarcinoma. Cancer Biol Ther. 7; 7: 1146-56, 2008.

39. Walter K, Omura N, Hong SM, Griffith M, Goggins M. Pancreatic cancer associated fibroblasts display normal allelotypes. Cancer Biol Ther. 7; 6: 882-8, 2008. 38. Alvarez H, Corvalan A, Roa JC, Argani P, Murillo F, Edwards J, Beaty R, Feldmann G,

Hong SM, Mullendore M, Roa I, Ibanez L, Pitmentel F, Diaz A, Riggins GJ, Maitra A. Serial Aanlysis of Gene Expression identified connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer. Clin Cancer Res. 14; 9: 2631-8, 2008.

37. Cho H, Hong SM. Median regression tree for analysis of censored survival data.IEEE Trans Syst Man Cybern A Syst Hum. 38; 3: 715-26, 2008.

36. Hong SM 2, Kim MJ, Jang KT, Yoon GS, Frierson HF Jr, Yu E. Adenosquamous Carcinoma of Extrahepatic Bile Duct: Clinicopathologic and Immunohistochemical Studies of 12 Cases with Comparison of 176 Adenocarcinoma Cases. Int J Clin Exp Pathol. 1; 2: 147-56, 2008.

35. Stelow EB, Hong SM, Covell JL, Moskaluk CA. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma. Cancer. 111; 3: 200-1, 2007.

Hong- 33

34. Hong SM, Cho H, Moskaluk CA, Yu E, Zaika AI. p63 and p73 expression in extrahepatic bile duct carcinoma and their clinical significance. J Mol Histol. 38; 3: 167-75, 2007.

33. Zen Y, Adsay V, Bardadin K, Colombari R, Ferrell L, Haga H, Hong SM, Hytiroglou P, Klöppel G, Lauwers GY, Leeuwen DV, Notohara K, Oshima K, Qualgia A, Sasaki M, Sessa F, Suriawinata A, Tsui W, Atomi Y, Nakanuma Y. Biliary intraepithelial neoplasia: An international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol. 20; 6: 701-709, 2007.

32 Hong SM, Hwang I, Song DE, Choi J, Yu E. Clinical and prognostic significances of nuclear and cytoplasmic KIT expressions in extrahepatic bile duct carcinomas. Mod Pathol. 20; 562-9, 2007. 31. Hong SM 2, Cho H, Moskaluk CA, Yu E. Measurement of invasion depth of extrahepatic bile duct carcinoma: An alternative method overcoming the current T classification problems of the AJCC staging system. Am J Surg Pathol. 31; 199-206, 2007.

30. Lee OJ, Hong SM, Razi MH, Peng D, Powell SM, Smoklin M, Moskaluk CA, El-Rifai W. Expression of calcium-binding proteins S100A2 and S100A4 in Barrett’s adenocarcinomas. Neoplasia. 8; 843-50, 2006. 29. Kim MJ, Hong SM, Jang SJ, Kim JS, Kim KR, Gong G, Ro JY. Invasive colorectal micropapillary carcinoma: an aggressive variant of adenocarcinoma. Hum Pathol. 37; 809-15, 2006.

28. Hong SM 2, Presley AE, Stelow EB, Frierson HF Jr, Moskaluk CA. Reconsideration of the histologic definitions used in the pathological staging of extrahepatic bile duct carcinoma. Am J Surg Pathol. 30; 744-749, 2006.

27. Hong SM, Choi J, Ryu K, Ro JY, Yu E. Promotor hypermethylation and loss of expression of the p16 gene is correlated with tumor progression in extrahepatic bile duct carcinomas. Arch Pathol Lab Med. 130;33-8, 2006.

26. Hong SM, Frierson HF Jr, Moskaluk CA. AP-2r protein expression in intratubular germ cell neoplasia of testis. Am J Clin Pathol. 124; 873-7, 2005.

25. Hong SM, Cho H, Moskaluk CA, Frierson HF Jr, Yu E, Ro JY. CDX2 and MUC2 protein expression in extrahepatic bile duct carcinoma. Am J Clin Pathol. 124; 361-70, 2005.

24. Hong SM, Kim MJ, Pi DY, Jo D, Yu E, Ro JY. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance. Hum Pathol. 36; 732-40, 2005.

23. Hong SM, Cho H, Lee YJ, Ro JY: The Number of Metastatic Lymph node in extrahepatic bile duct carcinoma as a prognostic factor. Am J Surg Pathol. 29; 1177-83, 2005.

22. Hong SM, Kim MJ, Pi DY, Jo D, Cho H, Yu E, Ro JY. Analysis of extrahepatic bile duct carcinomas according to the new American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients. Cancer. 104; 802-10, 2005.

21. Hong SM, Kim MJ, Pi DY, Jo D, Cho H, Yu E, Ro JY. Superficial versus deep pancreatic parenchymal invasion of the extrahepatic bile duct carcinoma: A significant prognostic factor.

Hong- 34

Mod Pathol. 18; 969-975, 2005.

20. Kim SK, Lim HK, Ryu JA, Choi D, Lee WJ, Lee JY, Lee JH, Sung YM, Cho EY, Hong SM, Kim JS. Radiofrequency ablation of rabbit liver in vivo: effect of the pringle maneuver on pathologic changes in liver surrounding the ablation zone. Korean J Radiol. 5; 240-249, 2004.

19. Ahn JH, Kim SW, Hong SM, Suh C, Kim WK, Lee IC, Lee JS. Epidermal growth factor receptor (EGFR) expression in operable non-small cell lung carcinoma. J Korean Med Sci. 19: 529-535, 2004.

18. Min K, Hong SM, Kim KR, Ro JY, Park MJ, Kim JS, Kim JM, Jung HC, Yu E. Intramucosal Helicobacter pylori in the human and murine stomach: its relationship to the inflammatory reaction in human Helicobacter pylori gastritis. Pathol Res Pract 199: 1-8, 2003. 17. Ha H, Hong SM, Lee SK, Khang SK. Congenital desmoplastic cerebral glioblastoma: a case report. Korean J Pathol 36: 365-373, 2002. 16. Park SH, Kim HS, Kim HK, Shin BK, Hong SM, Ro JY. Immunophenotype of thymic epithelial tumors according to the new world health organization classification. Korean J Pathol 35:278-285, 2001.

15. Park JW, Kim DI, Park SS, Seo DW, Lee SK, Kim MH, MinYI, Hong SM. Two Cases of Pancreatic Tuberculosis Masquerading as a Pancreatic Mass. Kor J Gastroenterol 35: 671-675, 2000.

14. Hong SM, Kang GH, Lee HY, Ro JY. Smooth muscle distribution in the extrahepatic bile duct: histologic and immunohistochemical studies of 122 cases. Am J Surg Pathol. 24:660-667, 2000.

13. Hong SM, Khang SK, Kim KK, Bae Y, Park SH. A case of myasthenia gravis proven by ultrastructural study. J Korean Med Sci. 15:251-4, 2000.

12. Hong SM, Ha H, Suh JH, Kim KK, Khang SK, Ro JY, Park SH. Clinicopathologic analysis of 124 biopsy-proven peripheral nerve diseases. J Korean Med Scie. 15:211-216, 2000.

11. Chang SE, Jung EC, Hong SM, Choi JH, Sung KJ, Moon KC, Koh JK. Keratosis lichenoides chronica: marked response to calcipotriol ointment. J Dermatol. 27:123-126, 2000.

10. Hong SM, Park YK, Ro JY. Chondroblastoma of the temporal bone: a clinicopathologic study of five cases. J Korean Med Sci. 14:559-564, 1999.

09. Huh J, Hong SM, Kim SS, Kim BS, Lee KH, Kim CW, Ro JY. Angiocentric lymphoma masquerading as acute appendicitis. Histopathol. 34:378-380, 1999.

08. Hong SM, Choe MS, Han EM, Lee HK, Ro JY. Prostatic Tissue in Ovarian Mature Cystic Teratoma: A case report. Korean J Pathol. 33:525-528, 1999.

07. Shin JW, Ryu JS, Kim JS, Moon DH, Hong SM, Gong GY, Hong SJ, Lee HK. Lesion Localization in Patients with Hyperparathyroidism Using Double-phase Tc-99m MIBI Parathyroid. Korean J Nuclear Med. 33: 120-130, 1999.

Hong- 35

06. Hong SM, Yoon GS, Kim YM, Lee HJ, Kang GH, Kim OJ. Secondary hemochromatosis in patient with aplastic anemia: an autopsy case report. Korean J Pathol. 32: 608-612, 1998.

05. Hong SM 2, Yu E, Ahn H, Kim OJ. Alpha-fetoprotein producing renal cell carcinoma: a case report. J Korean Med Sci. 13: 321-324, 1998.

04. Kim MK, Hong SB, Hong SM, Han DJ, Hong SJ, Kim SW, Shong YK, Lee KU, Kim GS. Multiple endocrine neoplasia type I presented with secondary amenorrhea and osteoporosis. Korean J Endocrinol. 13: 684-689, 1998.

03. Yeon KS, Na JH, Kim JH, Hong SM, Kim OJ, Mok JE. A Case of Ovarian Sex Cord Tumor with Annular Tubules Treated by Laparoscopic Surgery in 8 Year old Girl. Korean J Obstetrics Gynecol. 41: 2034-2038, 1998.

02. Suh JH, Hong SM, Lee IC. Clear Cell Ependymoma: A case report. Korean J Pathol. 31: 383-387, 1997.

01. Oh SJ, Kang SY, Hong SM, Paeng JR, Woo KT, Yang IM, Kim SW, Kim JW, Kim YS, Kim KW, Choi YK, Chang SG, Chai SE. Analysis of the urinary calculi composition in 917 cases of urolithiasis and the changing pattern in clinical finding during the recent 10 years. Korean J Med. 48: 38-45, 1995.

Hong- 36

Poster Presentations

74. Hong SM, Noë M, Yoshizawa T, Gaida MM, Thompson ED, Wolfgang C, Wirtz D, Wu PH, Braxton A, Keimen A, Hruban RH, Wood LD. Immunolabeling of cleared human pancreata for multiple markers provides insights into pancreatic anatomy and pathology. 108th Annual Meeting of the United States and Canadian Academy of Pathology, March 16-21, 2019 National Harbor, MD, USA.:

73. Jun SY, Park ES, Lee JJ, Chang HK, Jung ES, Oh YH, Hong SM. Prognostic significance of stromal and intra-epithelial tumor infiltrating lymphocytes in small intestinal adenocarcinoma. 108th Annual Meeting of the United States and Canadian Academy of Pathology, March 16-21, 2019 National Harbor, MD, USA.:

72. An S, Kim SJ, Kim SC, Seo DW, Hong SM. Histopathologic changes of pancreatic cysts after endoscopic ultrasound-guided ethanol and/or paclitaxel abration therapy mimic pseudocyst. 108th Annual Meeting of the United States and Canadian Academy of Pathology, March 16-21, 2019 National Harbor, MD, USA.:

71. Shin J, Lee JH, Song KB, Hwang DW, Kim SC, Hong SM. Utility and Pitfalls of Endothelial Makers Immunolabeling for Identifying Lymphovascular Invasion of Pancreatobiliary Tract Cancers. The 69th Annual Fall Meeting of Korean Society of Pathologists, Nov 10-11, 2017, The K hotel, Seoul, Korea

70. Shin J, Moon DB, Hong SM. Pancreatic ductal adenocarcinoma with autoimmune pancreatitis type 1-like features: A case report. The 69th Annual Fall Meeting of Korean Society of Pathologists, Nov 10-11, 2017, The K hotel, Seoul, Korea

69. Kim MJ, Kim SC, Hong SM. Mucinous cystic neoplasm of the pancreas with type 1 autoimmune pancreatitis-like features: A case report. The 69th Annual Fall Meeting of Korean Society of Pathologists, Nov 10-11, 2017, The K hotel, Seoul, Korea

68. Jun SY, Son D, Kim MJ, Kim SJ, An S, Park YS, Hong SM. Heterotopic Pancreas of the Gastrointestinal Tract and Associated Precursor and Cancerous Lesions: Systematic Pathological Studies of 165 Cases. 29th European Congress of Pathology, Sep 2-6 2017, Amstermdam, The Netherlands.

67. An S, Kim MJ, Kim SJ, Kim YW, Song KB, Hwang DW, Kim SC, Hong SM. KRAS mutations are predominant in non-mucinous lining epithelia of pancreatic mucinous cystic neoplasms. 29th European Congress of Pathology, Sep 2-6 2017, Amsterdam, The Netherlands. 66. Jeong BK, Sung YN, Kim SJ, An S, Park H, Kang HJ, Lee JH, Song KB, Hwang DW, Lee

SS, Kim SC, Hong SM. High-grade intraepithelial lesions are helpful for identifying origin of periampullary cancers. 29th European Congress of Pathology, Sep 2-6 2017, Amstermdam, The Netherlands.

65. Kwon JH, Kim HJ, Lee YJ, Hong SM. Incidentally Detected Pancreatic Neuroendocrine Microadenoma with Lymph Node Metastasis. 14th Annual ENETS Conference, Mar 8-10 2017

Hong- 37

Barcelona, Spain

64. Handra-Luca A, Romdhahane MB, Hong SM. Lithiasis in septate gallbladder: Relationship to body mass index and gallbladder length. 28th European Congress of Pathology, Sep 25-29 2016, Cologne, Germany.

63. Kim SJ, An S, Kang HJ, Yu E, Hong SM. Validation of ampulla of Vater cancer staging from the 8th edition of the American Joint Committee on Cancer staging system. The 68th Annual fall meeting of Korean Society of Pathologists, Oct 19-21, 2016, The K hotel, Seoul, Korea

62. An S, Kim SJ, Kim SC, Seo DW, Hong SM. Histopathologic changes of pancreatic cysts after endoscopic ultrasound-guided ethanol and/or paclitaxel ablation therapy. The 68th Annual fall meeting of Korean Society of Pathologists, Oct 19-21, 2016, The K hotel, Seoul, Korea

61. Byun SJ, Hong SM, Kim J, Yu E. Overlying mucosal changes in gastrointestinal stromal tumor. The 68th Annual fall meeting of Korean Society of Pathologists, Oct 19-21, 2016, The K hotel, Seoul, Korea

60. Kim JW, Hong ME, Shin MK, Kim BC, Jang SJ, Hong SM. The relationship between KRAS, NRAS, BRAF, PIK3CA, and TP53 mutations and tumor morphology and behavior in colorectal adenocarcinoma. 28th European Congress of Pathology, Sep 25-29 2016, Cologne, Germany.

59. Kim SW, Song IH, An S,Song KB, Hwang DW, Kim SC, Yu E,Hong SM. Not only neuroendocrine tumors but also other pancreatic tumors can be accompanied with serous cystic neoplasms even in patients without von Hippel-Lindau syndrome. 28th European Congress of Pathology, Sep 25-29 2016, Cologne, Germany.

58. Jun SY, An S, Lee JH, Park KM, Lee YJ, Hong SM. Gallbladder and cystic duct invasion of distal bile duct carcinomas. 105th Annual Meeting of the United States and Canadian Academy of Pathology, March 12-16, 2016 Seattle, WA, USA. 57. Kim JY, Brosnan-Cashman JA, An S, Jang KT, Lee KB, Kim H, Patk DY, Oh YH, Hruban

RH, Heaphy CM, Hong SM. 105th Annual Meeting of the United States and Canadian Academy of Pathology, March 12-16, 2016 Seattle, WA, USA. 56. Kim J, Brosnan-Cashman JA, An S, Jang KT, Lee KB, Kim H, Patk DY, Oh YH, Hruban RH,

Heaphy CM, Hong SM. Alternative lengthening of telomeres in carcinomas with acinar differentiation in the pancreas. 105th Annual Meeting of the United States and Canadian Academy of Pathology, March 12-16, 2016 Seattle, WA, USA.

55. Kim SJ, An S, Lee J, Song KB, Hwang DW, Kim SC, Hong SM. Loss of progesterone receptor expression in pancreatic neuroendocrine tumor.67th Annual Fall Meeting of Korean Society of Pathologists, October 14-16, 2015 Seoul, Korea

54. Kim SW, Song IH, An S, Song KB, Hwang DW, Yu E, Hong SM. Serous cystadenomas accompanying other pancreatic tumors. 67th Annual Fall Meeting of Korean Society of Pathologists, October 14-16, 2015, The-K hotel, Seoul, Korea

53. Park GY, Jeong SE, Song JS, Song DE, Yu E, Hwang DW, Hong SM. Primitive neuroectodermal tumors of the gallbladder: The second case report. 67th Annual Fall Meeting of Korean Society of Pathologists, October 14-16, 2015, The-K hotel, Seoul, Korea

Hong- 38

52. Jeong BK, Kim J, Lee JH, Hong SM. Granular cell tumor of the extrahepatic bile duct: A case report. 67th Annual Fall Meeting of Korean Society of Pathologists, October 14-16, 2015, The-K hotel, Seoul, Korea

51. Basturk O, Hong SM, Wood L et al. Recommendations for Assessing Precursor Lesions in the Pancreas. 104th Annual Meeting of the United States and Canadian Academy of Pathology, March 21-26, 2015 Boston, MA, USA.

50. Hong SA, Chun SM, Park H, An S, Lee JH, Kim KP, Yu E, Jang SJ, Hong SM. High Throughput Mutational Profiling of Biliary Neuroendocrine Carcinomas. 104th Annual Meeting of the United States and Canadian Academy of Pathology, March 21-26, 2015 Boston, MA, USA.

49. Schlitter AM, Jang KT, Klöppel G, Saka B, Hong SM, Choi H, Offerhaus GJ, Hruban RH, Zen Y, Konukiewitz B, Regel I, Allgäuer M, Balci S, Basturk O, Reid MD, Esposito I, Adsay V. Intraductal Tubulopapillary Neoplasms of the Bile Ducts: Further Immunohistochemical and Molecular Characterization. 104th Annual Meeting of the United States and Canadian Academy of Pathology, March 21-26, 2015 Boston, MA, USA.

48. Bagci P, Balci S, Saka B, Hong SM, Jang KT, Ohike N, Kim G, Krasinskas A, Basturk O, Sarmiento J. Sub-Staging of Nodal Status in Ampullary Carcinomas as N1 (< 3) and N2(>= 3) Has Significant Prognostic Value: Proposal for Revised Staging Based on an Analysis of 313 Cases. 104th Annual Meeting of the United States and Canadian Academy of Pathology, March 21-26, 2015 Boston, MA, USA

47. Chu HH, Park CS, Chung JY, Yu E, Hong SM. Intratumoral CD8+ T lymphocytes infiltration as a better prognostic indicator in small intestinal adenocarcinomas. 66th Annual Fall Meeting of Korean Society of Pathologists, October 16-17, 2014, The-K hotel, Seoul, Korea

46. Shin SJ, Park H, Park CS, Yu E, Hong SM. Prognosis of pancreatic cancer patients with synchronous or metachronous malignancies is better than patients with pancreatic cancer only. 66th Annual Fall Meeting of Korean Society of Pathologists, October 16-17, 2014, The-K hotel, Seoul, Korea

45. Park H, An S, Yu E, Hong SM. Extrabiliary malignancies are not common in patients with intraductal papillary neoplasm of the bile duct. 66th Annual Fall Meeting of Korean Society of Pathologists, October 16-17, 2014, The-K hotel, Seoul, Korea

44. Park IA, Kim JY, Park YS, Kim J, Yu E, Hong SM. Hormonal Expression in Gastrointestinal Neuroendocrine Tumors. 66th Annual Fall Meeting of Korean Society of Pathologists, October 16-17, 2014, The-K hotel, Seoul, Korea

43. Kim JY, Kim KS, Song KB, Jang HJ, Yu E, Kim SC, Park JY, Hong SM. Prognostic significance of hormonal expression in pancreatic neuroendocrine tumor. 26th European Congress of Pathology, Aug 30-Sep 3 2014, London, United Kingdom.

42. Kim JY, Song JS, Park H, Byun JH, Song KB, Kim JKP, Kim SC, Hong SM. Primary Mesenchymal Tumors of the Pancreas. 26th European Congress of Pathology, Aug 30-Sep 3 2014, London, United Kingdom. 41. An S, Park H, Song KB, Lee JH, Park DH, Lee SS, Seo DW, Kim SC, Lee SK, Yu E, Kim

Hong- 39

MH, Seung-Mo Hong SM. Histopathologic changes of bile ducts after biliary instrumental insertion: review of 239 consecutive pancreaticoduodenectomy cases. 26th European Congress of Pathology, Aug 30-Sep 3 2014, London, United Kingdom.

40. Jun SY, An S, Yu E, Chung JY, Hong SM. Olfactomedin 4 expression is associated with Less aggressive behavior of the extrahepatic cholangiocarcinomas. 26th European Congress of Pathology, Aug 30-Sep 3 2014, London, United Kingdom.

39. Min KW, An S, Kang HJ, Kim SC, Park KM, Lee YJ, Yu E, Hong SM. Duodenal Invasion Is Under-Staged in Distal Bile Duct Carcinoma Staging of the 7th AJCC Cancer Staging System. 103rd Annual Meeting of the United States and Canadian Academy of Pathology, March 1-7, 2014 San Diego, CA, USA

38. Schlitter AM, Jang KT, Saka B, Choi H, Offerhaus GJ, Hruban R, Zen Y, Hong SM, Konukiewitz B Allgauer M, Esposito I, Kloppel G, Reid M, Adsay V. Intraductal Tubulo-Papillary Neoplasms of the Bile Ducts: Clinicopathologic and Immunohistochemical Analysis of 19 Cases. 103rd Annual Meeting of the United States and Canadian Academy of Pathology, March 1-7, 2014 San Diego, CA, USA.

37. Bagci P, Balci S Saka B, Hong SM, Jang KT, Ohike N, Kim G, Krasinskas A, Basturk O, Sarmiento J, Kooby D, El-Rayes B, Maithel S, Knight J, Goodman M, Adsay V. Sub-Staging of Nodal Status in Ampullary Carcinomas as N1 (< 3) and N2(>= 3) Has Significant Prognostic Value: Proposal for Revised Staging Based on an Analysis of 313 Cases. 103rd Annual Meeting of the United States and Canadian Academy of Pathology, March 1-7, 2014 San Diego, CA, USA.

36. Hong SA, Kim J, Yu E, Hong SM. Xanthogranulomatous cholecystitis manifestating IgG4-related cholecystitis, International symposium on IgG4-RD & associated conditions. February 16-19, 2014, Honolulu, HI, USA.

35. Park H, Eo S, Yu E, Cho H, Song KB, Kim SC, Hong SM. Survival in pancreatic cancer patients with tumor size <2cm and extension beyond pancreas is worse than those with >2cm and limited to pancreas. The 8th Asia Pacific IAP Congress. Sep 5-8, 2013, Busan, Korea.

34. Park H, Chun SM, Yu E, Jang SJ, Hong SM. Mutational profiling of small intestinal adenoma and adenocarcinoma. The 8th Asia Pacific IAP Congress. Sep 5-8, 2013, Busan, Korea.

33. Park JY, Kim KR, Kim SC, Hong SM. Significance of microcystic, elongated and fragmented like glandular features of intraductal papillary mucinous neoplasm of the pancreas. The 8th Asia Pacific IAP Congress. Sep 5-8, 2013, Busan, Korea.

32. Min KW, Kang HJ, Yu E, Hong SM. Gruoping based on invasion depth is a better alternative method overcoming the 7th edition of the American Joint Committee on Cancer staging system for distal bile duct carcinomas: Anlysis of 291 cases. The 8th Asia Pacific IAP Congress. Sep 5-8, 2013, Busan, Korea.

31. Kim JY, Kim KS, Park Y, Park YS, Yu E, Jang HJ, Hong SM. Glugacon-like peptide (GLP1) and PYY expressisons in gastroenteropancreatic neuroendocrine tumors and its prognostic signficances. The 8th Asia Pacific IAP Congress. Sep 5-8, 2013, Busan, Korea.

Hong- 40

30. An, Kim SA, Eo SH, Cho H, Hong SM. Comparison of CK7 and CK20 expression between sporadic and inflammatory bowel diseases-associated colorectal adenocarcinomas. The 8th Asia Pacific IAP Congress. Sep 5-8, 2013, Busan, Korea.

29. Park HS, Pak D, Kang HJ, Yu, E, Cho H, Hong SM. New Nodal Classification Discriminates Better Survival Time Than That of the 7Th AJCC Cancer Staging in Patients with Small Intestinal Adenocarcinoma (SIAC): An Analysis with the SEER Database. 102nd Annual Meeting of the United States and Canadian Academy of Pathology, March 2-8, 2013, Baltimore, MD, USA.

28. Shin HC, Kim A, Bae YK, Gu MJ, Jung ES, Oh YH, Bae HI, Lee HJ, Hong SM. Epithelial-Mesenchymal Transition Phenotype Is Associated with Patient Survival in Small Intestinal Adenocarcinoma. 102nd Annual Meeting of the United States and Canadian Academy of Pathology, March 2-8, 2013, Baltimore, MD, USA.

27. Min KW, Koh YW, Ryu YJ, Hong SM, Kim KR, Sung CH. A primary clear cell carcinoma associated with rectal endometriosis. 64th annual fall meeting of the Korean Society of Pathologists, Oct 17-19 2012, Imperial palace hotel, Seoul, Korea

26. Woo CG, Hong SM, Kim SC, Yu E. Solitary fibrous tumor of the pancreas a case report. 64th annual fall meeting of the Korean Society of Pathologists, Oct 17-19 2012, Imperial palace hotel, Seoul, Korea

25. Song IH, Yu E, Hong SM. Seous adenomas of the pancreas: Not always cystic neoplasms. 64th annual fall meeting of the Korean Society of Pathologists, Oct 17-19 2012, Imperial palace hotel, Seoul, Korea

24. An S, Jang J, Min K, Park Y, Cho KJ, Yu E, Hong SM. Clinicopathological characteristics of granular cell tumor of the gastrointestinal tract. 64th annual fall meeting of the Korean Society of Pathologists, Oct 17-19 2012, Imperial palace hotel, Seoul, Korea

23. Song M, Kim MS, Kim SA, Yu E, Jang KT, Hong SM. Adenosquamous carcinoma of the gallbladder clincipathologic study of 37 cases. 64th annual fall meeting of the Korean Society of Pathologists, Oct 17-19 2012, Imperial palace hotel, Seoul, Korea

22. Jun SY, Eom DW, Bae YK, Jang KT, Hong SM. CDX2 and MUC protein expression in small intestinal adenocarcinomas and their prognostic significances. 24th European Congress of Pathology, Sep 8-12 2012, Prague, Czech Republic.

21. Kang HJ, Eo SH, Yu ES, Cho H, Hong SM. The number of metastatic lymph nodes in adenocarcinoma of ampulla of Vater as a prognostic factor. 24th European Congress of Pathology, Sep 8-12 2012, Prague, Czech Republic.

20. Hong SM, Goggins M, Wolfgang CL, Schulick RD, Edil BH, Cameron JL, Handra-Luca A, Herman JM, Hruban RH. Vascular Invasion in Infiltrating Ductal Adenocarcinoma of the Pancreas Can Mimic Pancreatic Intraepithelial Neoplasia: A Histopathologic Study of 209 Cases. 101st Annual Meeting of the United States and Canadian Academy of Pathology, March 18-22, 2012 Vancourver, British Columbia, Canada.

19. Roh J, de Wilde R, Chung JY, Kim J, Yu E, Hong SM. Loss of PTEN expression in small intestinal adenocarcinoma in association with cancer progression and worse survival. 63th

Hong- 41

annual fall meeting of the Korean Society of Pathologists, Oct 19-21 2012, Imperial palace hotel, Seoul, Korea

18. Matthaei H, Hong SM, dal Molin M, Goggins M, Cameron JL, Schulick RD, Maitra A, Hruban RH. Presence of pancreatic intraepithelial neoplasia in the permanent transection margin does not influence outcome in patients with R0 Resected pancreatic cancer, 64th Annual Cancer Symposium, Society of Surgical Oncology, March 2-5, 2011 San Antonio, TX.

17. Matthaei H, Norris-Kirby A, Tsiatis AC, Hong SM, Olino K, Wolfgang CL, Schulick RD, Cameron JL, Jackson KD, Capelli P, Zamboni G, Bortesi L, Furukawa T, dal Molin M, Goggins M, Eshleman JR, Hruban RH, A. Maitra, Multifocal IPMNs: pathology and field defect, 41st Annual Meeting of the American Pancreatic Association, November 3-6 Chicago, IL.

16. Hong SM, Heaphy CM, Shi C, Eo SH, Cho H, Meeker AK, Eshleman JR, Hruban RH, Goggins M. Telomeres are shortened in acinar-to-ductal metaplasia lesions associated with pancreatic intraepithelial neoplasia but not in isolated acinar-to-ductal metaplasias. 99th Annual Meeting of the United States and Canadian Academy of Pathology, March 20-26, 2010 Washington, DC.

15. Sung WJ, Bae YK, Hong SM. Expression of Mismatch Repair Genes, HMLH1, HMSH2 and HMSH6 in 195 Small Intestinal Adenocarcinomas. 99th Annual Meeting of the United States and Canadian Academy of Pathology, March 20-26, 2010 Washington, DC.

14. Park, JY, Hong SM, Klimstra DS, Goggins MG, Maitra A, Hruban RH. Pdx1 Expression in Pancreatic Precursor Lesions and Neoplasms. 99th Annual Meeting of the United States and Canadian Academy of Pathology, March 20-26, 2010 Washington, DC.

13. Hong SM, Pawlik TM, Cho H, Aggarwal B, Goggins M, Hruban RH, Anders RA. Simplified Staging for Extrahepatic Bile Duct Carcinoma. 98th Annual Meeting of the United States and Canadian Academy of Pathology, March 07-13, 2009 Boston, MA.

12. Shi C, Hong SM, Lim P, et al. : Immunohistochemical and Molecular Characterization of Incipient Intraductal Papillary Mucinous Neoplasms. 98th Annual Meeting of the United States and Canadian Academy of Pathology, March 07-13, 2009 Boston, MA.

11. Hong SM, Yu E, Kim JH, et al. Adenocarcinoma of the Small Intestine: A Multi-Institutional Study of 197 Cases98th Annual Meeting of the United States and Canadian Academy of Pathology, March 07-13, 2009 Boston, MA. 10 . Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma. 70th Annual Meeting of the Society-of-University-Surgeons/4th Annual Academic Surgical Congress, FEB 03-06, 2009 Ft Myers, FL

9. Hong SM, Cho H, Choi BY et al. New cutoff points of tumor size discriminates patients' survival time more precisely than T classification of the 6th AJCC cancer staging system of breast carcinoma. 97th Annual meeting of United States and Canadian Academy of Pathology, March 1-7 2008, Denver, Colorado, USA.

8. Shi C, Hong SM, Lim P, Kamiyama H, Khan M, Anders RA, Goggins M, Hruban RH, Eshleman JR. KRAS2 gene mutations in acinar-ductal metaplasia in the pancreas: Pancreatic

Hong- 42

neoplasia may start prior to pancreatic Intraepithelial neoplasia lesions. 97th Annual meeting of United States and Canadian Academy of Pathology, March 1-7 2008, Denver, Colorado, USA.

7. Policarpio-Nicolas MC, Stoler MH, Stelow EB, Moskaluk CA, Hong SM, Frierson HF Jr. Human papillomavirus and p16 status in 438 head and neck squamous cell carcinomas. 97th Annual meeting of United States and Canadian Academy of Pathology, March 1-7 2008, Denver, Colorado, USA

6. Jang KT, Hong SM, Lee KT, Lee JG, Choi SH, Heo JS, Choi DW, Choi D, Lim JH. Intraductal papillary neoplasm of the bile duct associated with Clonorchis sinensis infection 3rd International Congress of Pathology, May 20 2008, Barcelona, Spain.

5. Hong SM, Kelly D, Griffith M, Omura N, Li A, Li CP, Hruban RH, Goggins M. Hypermethylation of multiple genes in intraductal papillary mucinous neoplasms of the pancrease. Digestive Disease Week, May 7 2008, San Diego, California, USA.

4. Kim MJ, Hong SM, Jang SJ, Kim JS, Kim KR, Gong G, Ro JY. Invasive colorectal micropapillary carcinoma: an aggressive variant of adenocarcinoma. 96th Annual meeting of United States and Canadian Academy of Pathology, February 28, 2005, San Antonio, TX, USA.

3. Hong SM, Kim MJ, Pi DY, Jo D, Yu E, Ro JY. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance. 95th Annual meeting of United States and Canadian Academy of Pathology, March 6-12, 2004, Vancourver, British Columbia, Canada.

2. Hong SM, Kim MJ, Pi DY, Jo D, Cho H, Yu E, Ro JY. Analysis of extrahepatic bile duct carcinomas according to the new American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients. 95th Annual meeting of United States and Canadian Academy of Pathology, March 6-12, 2004, Vancourver, British Columbia, Canada.

1. Hong SM, Kim MJ, Pi DY, Jo D, Cho H, Yu E, Ro JY. Superficial versus deep pancreatic parenchymal invasion of the extrahepatic bile duct carcinoma: A significant prognostic factor. 95th Annual meeting of United States and Canadian Academy of Pathology, March 6-12, 2004, Vancourver, British Columbia, Canada.

Hong- 43

Supervision of Platform Presentations

18. Hwang HS, Kim MJ, Hwang S, Hong SM. Smooth muscle distribution patterns of choledochal cyst. The 69th Annual Fall Meeting of Korean Society of Pathologists, Nov 10-11, 2017, The K hotel, Seoul, Korea

17. Lee SJ, Sung YN, Kim SJ, Kim YW, Jang MA, Cho HJ, Hong SM. PanIN-like pattern and high frequency of lymphovascular invasion are associated with worse overall survival in patients with pancreatic ductal adenocarcinoma. The 69th Annual Fall Meeting of Korean Society of Pathologists, Nov 10-11, 2017, The K hotel, Seoul, Korea

16. Lee M, Yoo C, Kim KP, Hwang DW, Kim SC, Hong SM. Metastatic pancreatic tumors: Clinicopathologic studies of 119 cases. The 69th Annual Fall Meeting of Korean Society of Pathologists, Nov 10-11, 2017, The K hotel, Seoul, Korea 15. Lee G, Sung YN, Kim SJ, Lee JH, Song KB, Hwang DW, Lee SS, Seo DW, Lee SK, Kim

SC, Yu E, Hong SM. Large tumor size, lymphovascular invasion, and synchronous metastasis are associated with recurrence of solid pseudopapillary neoplasm. The 69th Annual Fall Meeting of Korean Society of Pathologists, Nov 10-11, 2017, The K hotel, Seoul, Korea

14. An S, Sung YN, Kim SJ,Park H, Lee JH, Hwang S, Yu E, Zen Y, Hong SM. Comparative analysis of clinicopathologic characteristics between intraductal papillary neoplasms of bile duct and papillary cholangiocarcinomas. The 69th Annual Fall Meeting of Korean Society of Pathologists, Nov 10-11, 2017, The K hotel, Seoul, Korea

13. Sung YN, Kim SJ, Hwang S, Yu E, Zen Y, Hong SM. Comparative clinicopathological study of intracholecystic papillary neoplasm, papillary carcinoma, and conventional adenocarcinoma of the gallbladder. The 69th Annual Fall Meeting of Korean Society of Pathologists, Nov 10-11, 2017, The K hotel, Seoul, Korea.

12. Sung YN, Kim SJ, Yoo C, Kim KP, Hwang S, Hong SM. HER2 and mismatch repair proteins expression status in gallbladder adenocarcinoma. The 69th Annual Fall Meeting of Korean Society of Pathologists, Nov 10-11, 2017, The K hotel, Seoul, Korea. 11. Kim SJ, Kim MJ, Han JS, Sung NY, An S, Song KB, Hwang DW, Lee SS, Eshleman JR,

Kim SC, Hong SM. Development of recurrence prediction biomarker with ultrasensitive-digital PCR on resection margin of surgically resected pancreatic ductal adenocarcinoma specimen. The 69th Annual Fall Meeting of Korean Society of Pathologists, Nov 10-11, 2017, The K hotel, Seoul, Korea.

10. Kim SJ, Kang HJ, Ahn CS, Hwang S, Yu E, Zen Y Hong SM. Perihilar type intrahepatic cholangiocarcinomas have more aggressive clinicopathologic features than peripheral type cancers. The 69th Annual Fall Meeting of Korean Society of Pathologists, Nov 10-11, 2017, The K hotel, Seoul, Korea 9. Hwang HS, Kim YJ, An S, Kim SJ, Kim JY, Kim SY, Hwang SW, Park DH, Lee SS, Kim SC,

Seo DW, Hong SM. Grading by the Ki-67 labeling index of endoscopic ultrasound-guided fine needle aspiration biopsy specimens of pancreatic neuroendocrine tumors can be underestimated. The 68th Annual fall meeting of Korean Society of Pathologists, Oct 19-21, 2016, The K hotel, Seoul, Korea

Hong- 44

8. An S, Kim MJ, Kim SJ, Kim YW, Song KB, Hwang DW, Kim SC, Hong SM. KRAS mutations are predominant in non-mucinous lining epithelia of pancreatic mucinous cystic neoplasms. The 68th Annual fall meeting of Korean Society of Pathologists, Oct 19-21, 2016, The K hotel, Seoul, Korea

7. Sung YN, Song M, Ahn CS, Hwang S, Lee YJ, Yu E, Hong SM. Validation of gallbladder cancer staging from the 8th edition of the American Joint Committee on Cancer (AJCC) cancer staging system. The 68th Annual fall meeting of Korean Society of Pathologists, Oct 19-21, 2016, The K hotel, Seoul, Korea 6. Kim JY, Brosnan-Cashman JA, An S, Jang KT, Lee KB, Kim H, Patk DY, Oh YH, Hruban

RH, Heaphy CM, Hong SM. Alternative lengthening of telomeres in carcinomas with acinar differentiation in the pancreas. 67th Annual Fall Meeting of Korean Society of Pathologists, October 14-16, 2015 Seoul, Korea

5. Kim JY, Brosnan-Cashman JA, An S, Meeker AK, Yu E, Hruban RH, Heaphy CM, Hong SM. Alternative lengthening of telomeres in primiary pancreatic neuroendocrine tumors is associated with aggressive clinical behavior and poor survival, but better survival after metastasis. 67th Annual Fall Meeting of Korean Society of Pathologists, October 14-16, 2015 Seoul, Korea

4. Kim MS, Eon DW, Yu E, Hong SM. KRAS and BRAF mutation of primary small intestinal carcinoma. The 64th annual fall meeting of the Korean Society of Pathologists, Oct 17-19 2016, Imperial palace hotel, Seoul, Korea

3. Park HS, Park D, Kang HJ, Yu E, Cho H, Hong SM. New nodal classification discriminates better survival time than that of the 7th AJCC cancer staging in patients with small intestinal adenocarcinoma (SIAC): An analysis with the SEER database. 64th annual fall meeting of the Korean Society of Pathologists, Oct 17-19 2016, Imperial palace hotel, Seoul, Korea

2. Kang HJ, Yu E, Eo SH, Cho H, Hong SM. Increased number of metastatic lymph nodes better predict patients’ survival than the current American Joint Committee on Cancer N classification for ampullary carcinoma. 64th annual fall meeting of the Korean Society of Pathologists, Oct 17-19 2016, Imperial palace hotel, Seoul, Korea

1. Kim SA, Kim MS, Kim MS, Kim SC, Choi J, Yu E, Hong SM. Pleomorphic solid

pseudopapillary neopla는 of the pancreas with TP53 mutation. 64th annual fall meeting of the

Korean Society of Pathologists, Oct 17-19 2016, Imperial palace hotel, Seoul, Korea

Hong- 45

Invited Lectures

60. A ‘Clearer’ View of Pancreatic Pathology. KOPANA 18th spring seminar of the Korean Pathologists Association of North America, Mar 15, 2019, National Harbor, MD, USA. 59. Role of Gastrointestinal Pathologists for Diagnosis of Parkinson's Disease. Aug 24 2018,

Department of Biochemistry and Molecular Biology Mayo Clinic, Rochester, MN, USA 58. Granulocytic epithelial lesion (GEL): Is it really specific to type 2 AIP? AOPA & KPBA & KPSC 2018 (Joint meetining of the Asian-Oceanic Pancreatic Asssociation, the Korean Pancreatobiliary Association, and the Korean Pancreas Surgery Club 2018), Apr 26 2018, Lotte Hotel, Seoul, Korea 57. Pathologic overview of pancreatobiliary disease. CME Course, Korean Society of Abdominal Radiology, Nov 19 2017, Yonsei University Severance Hospital, Seoul, Korea 56. Importance of understanding of normal histology for determining cancer staging. 67th Annual Meeting of The Korean Association of Anatomists, Oct 19 2017, BEXCO, Busan, Korea 55. Guide of EUS-FNA specimen handling for cytopathology diagnosis. 57th Digestive Endoscopy Seminar, Aug 27 2017, KIDEX, Ilsan, Korea 54. Fine needle aspiration cytology of the pancreas. 27th Cytopathology education for pathologists, Jul 1 2017, Asan Medical Center, Seoul, Korea 53. Updates of Pancreatic Neuroendocrine Tumors. 10th Asia Pacific International Academy of Pathology Congress. Apr 27 2017, Nusa Dua Conveniton Center, Bali, Indonesia 52. Histological features of precancerous and early cancerous lesions of biliary tract cancers. 2nd International Conference of the Korean Pancreatobiliary Association. Apr 7 2017, Grand Hilton Hotel, Seoul, Korea 51. Principles of cancer staging. Monthly seminar, Surgical Pathology Companion Meeting. Apr 5 2017, Hanyang University Hospital, Seoul, Korea 50. Updates of pancreatic precursor lesions: A tale of two cities. 17th Surgical Pathology CME course. Dec 10 2016, Asan Medical Center, Seoul, Korea 49. Non-ductal neoplasm of the pancreas. Seoul National University Graduate School. Nov 29 2016 Bundang Seoul National University Hospital, Seongnam, Korea 48. Updates of pancreatic precursor lesions: A tale of two cities. Asan Medical Center Pancrreas Cancer Symposim. Nov 17 2016, Asan Medical Center, Seoul, Korea 47. Three things you must know about frozen section diagnosis of pancreatobiliary tract. 16th Annual Current Topics in GI and Liver Pathology. Oct 16 2016, Johns Hopkins Medical Institutions, Baltimore, MD, USA 46. Recent updates of pancreatic neuroendocrine tumor pathology. Asan Cancer Institute Symposium 2016, Sep 02 2016, Asan Medical Center, Seoul, Korea

Hong- 46

45. Updates and issues of pancreatic precursor lesions: Pathologists’s perspective: A tale of two cities. Joint Conference of IAP, JPS, and AOPA, Aug 08 2016, Sendai, Japan 44. Fine needle aspiration cytology of the pancreas. 26th Cytopathology education for pathologists, Jul 16 2016, Asan Medical Center, Seoul, Korea 43. Assessment of Diagnostic Sufficiency, Specimen Handling, and Ancillary Studies: A Lesson from Pathologist. International Digestive Endoscopy Network 2016, Jun 26 2016, Grand Hilton Hotel, Seoul, Korea 42. Updates of the pancreatobiliary system in the 8th edition of AJCC cancer staging. Pathology-Radiology conference, Asan Medical Center, Jun 22, 2016, Seoul, Korea. 41. Practical Approach of Cancer Staging by AJCC: Pancreatobiliary system. Monrhly seminar, Korean Society of Pathologists Special Lecture, Samsung Medical Center, Jun 17, 2016, Seoul, Korea. 40. Pattern diagnosis with Vincent van Gogh’s paintings: Glandular and pseudoglandular pattern. Monthly seminar, Surgical Pathology Companion Meeting, Korea University Hospital, Feb 3, 2016, Seoul, Korea. 39. Clinical significance of histologic subtype of IPMN. 10th International Single Topic Symposium of the Korean Association of HBP Surgery. Sep 18. 2015, Yonsei University Severance Hospital, Seoul, Korea 38. What pathologists wants from EUS-FNA: Pathologist’s Perspective. 1st Asian EUS Congress. Sep 11. 2015, Asan Medical Center, Seoul, Korea 37. Gastric cancers from gross to microscopic examination. The 8th Mongolian-Korean Joint Workshop Program. August 24. 2015, Mongolian National University of Medical Science Ulaanbaatar, Mongolia. 36. A practical approach to the diagnosis of pancreatic tumors from gross to microscopic examination. Gangnam Severance Hospital, May 12. 2015, Seoul, Korea 35. Recent updates of neuroendocrine tumors of the gastrointestinal tract. CME course Korean Society of Pathologists. Seoul St. Mary Hospital, The Catholic University, Apr 11. 2015, Seoul, Korea. 34. Recent updates of gastrointestinal tract and pancreatobiliary neuroendocrine tumors. 14th Spring Seminar Korean Pathologist Association North America, Midtown Hotel. Mar 19, 2015, Boston, MA, USA. 33. Three things you must know about frozen section diagnosis of pancreatobiliary tract. Monthly seminar. Surgical Pathology Study Group. Korea University Anam Hospital, Feb 11, 2015 Seoul, Korea. 32. Fine needle aspiration cytology of the pancrease. 25th Cytopathology education for pathologists. Asan Medical Center, Jan 31, 2015, Seoul, Korea 31. Recent Updates on Pancreatic Precursor Lesions: Revised Recommendations for Assessing Precursor Lesions in the Pancreas. 15h AMC surgical pathology update. Asan

Hong- 47

Medical Center, Dec 6, 2014 Seoul, Korea 30. Histologic Characteristics of Invasive Carcinoma in IPMN. Asan Cancer Center Symposium Aug 29, 2014, Seoul, Korea 29. Recent concept of pancreatic cystic neoplasm. 9th Asan medical center surgery symposium. Asan Medical Center, Jul 5, 2014, Seoul, Korea. 28. PanIN and IPMN at margin. Intraductal neoplasia group. PanIN classification meeting, Johns Hopkins Medical Institutions, Jun 17th 2014, Baltimore, MD, USA. 27. Neuroendocrine tumors of pancreato-biliary tract. Short course. Annual spring meting. The Korean Society of Pathologists, May 15, 2014, Gyeongju, Korea. 26. Duodenal Invasion Is Under-Staged in Distal Bile Duct Carcinoma Staging of the 7th AJCC Cancer Staging System, 103rd Annual Meeting of the United States and Canadian Academy of Pathology, March 1-7, 2014 San Diego, CA, USA. 25. Fine needle aspiration cytology of the pancreas. 24th cytopathology education for pathologists, Asan Medical Center, Jan 25, 2014, Seoul, Korea. 24. Genetic and epigenetic changes of precursor lesions of the pancreatic cancer. Monday Seminar, Yonsei University Severance Hospital, Dec 23, 2013, Seoul, Korea 23. Practical approach to intestinal polyposis syndrome. 14th AMC surgical pathology update. Asan Medical Center, Dec 14, 2013, Seoul, Korea 22. Development of tablet microscope for effective pathologic diagnosis. 2013 POSTEC-AMC R&DPartnering symposium, Nov 8, 2013, Pohang, Korea. 21. Pattern diagnosis with Vincent van Gogh’s paintings: Glandular and pseudoglandular pattern. Monthly seminar, Surgical Pathology Companion Meeting, Korea University Hospital, Oct 2, 2013, Seoul, Korea. 20. Staging of the pancreatobiliary tract cancers: Updates and validation. The 8th Asia Pacific IAP Congress. Sep 6, 2013, Busan, Korea. 19. Frozen biopsy: Accuracy and methods to overcome its limitation. Joint meeting of the International Association of Pancreatology and the Korean Pancreatobiliary Association. Sep 5, 2013, Seoul, Korea. 18. A practical approach to the diagnosis of pancreatic tumors from gross to microscopic examination. Pusan National University Hospital, Jul 1, 2013, Busan, Korea. 17. Benign mimics of malignancy in GI tract. Monthly seminar, Surgical Pathology Companion Meeting, Asan Medical Center, Jun 5, 2013, Seoul, Korea 16. Pathology and prognostic factors of gastrointestinal and pancreatic neuroendocrine tumors. Annual Meeting, Korean Society of Clinical Oncology, Samsung Medical Center, Mar 9, 2013, Seoul, Korea. 15. Changes of pathologic diagnostic criteria of pancreatic neuroendocrine tumors. CME

Hong- 48

course, Korean Association of HPB Surgery, Seoul National University Hospital, Feb 23, 2013, Seoul, Korea. 14. Biospy interpretation of inflammatory bowel disease. 13th AMC surgical pathology update. Asan Medical Center, Dec 1, 2012, Seoul, Korea 13. A river runs thorugh it: A story of cancer staging. Pathology Grand Round. Samsung Medical Center, Nov 7, 2012, Seoul, Korea. 12. Genetic and epigenetic changes of precursor lesions of the pancreatic cancer. Monthly Seminar. The Gastrointestinal Pathology Study Group. Gangneung Asan Hospital, Aug 31, 2012, Gangneung, Korea. 11. Small intestinal adenocarcinoma: A series of small studies. Seminar in Colorectal disease, Asan Medical Center, Jun 22, 2012, Seoul, Korea 10. Genetic and epigenetic changes of precursor lesions of the pancreatic cancer. Medical Genetics Center Seminar, Asan Medical Center, May 22, 2012, Seoul, Korea. 9. Tumors and tumor-like conditions of biliary tract. CME Course. The Korean Society of Pathologists, Seoul National University Hospital, Apr 14 2012, Seoul, Korea. 8. A river runs thorugh it: A story of cancer staging. Pathology Lecture. Department of Pathology. Seoul National University Hospital, Mar 27, 2012, Seoul, Korea. 7. Pathologic overview of pancreatic disease. CME Course. Korean Society of Abdominal Radiology. Yonsei University Sevrance Hospital, Mar 11, 2012, Seoul, Korea. 6. Liver and gallbladder. The 2nd pathologist assistant education program. Asan Medical Center, Feb 5, 2012, Seoul, Korea. 5. Small intestinal adenocarcinoma: A series of small studies. The 9th Korea-Japan gastrointestinal pathology seminar. Soon Chun Hyang University Hospital, Dec 9, 2011, Seoul, Korea. 4. A practical approach to the diagnosis of pancreatic tumors. 12th AMC surgical pathology update. Asan Medical Center, Dec 3, 2011, Seoul, Korea. 3. Histopathology and classification of gastrointestinal tract and pancreatic neuroendocrine tumors. Seoul International Digestive Disease Symphosium 2011, Nov 17, 2011, Seoul, Korea. 2. A river runs thorugh it: A story of cancer staging. Thursday Pathology Seminar, Department of Pathology, Asan Medical Center, Sep 8, 2011, Seoul, Korea. 1. Update on pancreatic cancer and its precursor lesions. KOPANA 9th spring seminar, Mar 19, 2010, Washington DC, USA.

Hong- 49

Patents

2. Method for predicting recurrence of surgically resected pancreatic cancer patient (10-2019-0033176) 1. Antibody specifically bound to PAUF protein (10-2017-0096370, PCT/KR2017/008893)

Updated 8/06/2019